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Abstract
Computational modeling of biological macromolecules through molecular dynamics (MD)
simulations is becoming increasingly useful to interpret the experimental results and guide the
future experiments. Over the last decade, MD simulations have become much more powerful and
accessible due to advancements in fields of structural biology, computer science and integrated
chip design. In this thesis, I utilize different MD simulation techniques to model interaction of and
antiviral mechanisms. Within the framework of nucleic acid modelling, we describe first dynamics
of small circular single stranded nucleic acids and highlight key dynamical differences of backbone
behavior in solution between DNA and RNA and their ability to capture ions for much longer
timescales as compared with linear nucleic acids. Second, we model single stranded DNA corona
on carbon nanotubes (CNT) and quantify the number of nucleotides that cover CNTs. Third, we
modelled melting mechanisms of DNA duplexes on laser-excited gold nanoparticles, which can
provide control over heating in biological systems through laser-based sources. Within the
framework of modeling of antiviral mechanisms, first, I describe computational models of
APOBEC3G protein, which is known to restrict HIV-1 virus, and examine its interactions with
ssDNA. Next, we model broad-spectrum antivirals nanoparticles, mimicking heparan sulfate
proteoglycans against human papillomavirus (HPV) in which we identify viral capsid regions that
facilitate binding with such nanoparticles. Lastly, I propose peptide-based therapeutics for fast
mutating SARS-CoV-2 virus and design an adaptive algorithm to generate peptide templates
against different mutants of SARS-CoV-2.
.
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Chapter 1: Introduction
The understanding of the biomolecule structures provides key knowledge to our
understanding of the living world. Biomolecule structures, determined by interactions of particles
comprising the biomolecules, determine the biological function..1 Since initial structure
determinations of biomolecules in the 1950s, our knowledge of such macromolecular structures
has been increasing. At present, protein data bank (PDB)2 holds more than 155,000 entries,
including more than 130,000 proteins, approximately 2,100 nucleic acids and 7200 complexes of
protein-nucleic acids. Such structural knowledge advances our understanding of basic biological
phenomena such as translation, transcription, transport across membranes, enzyme regulation etc.
Despite their enormous impact, structures stored at the PDB do not capture complete dynamics of
such flexible biomolecules, which play a key role in their functionality. Ideally, one would like to
watch these biomolecules in action, to perturb them at the atomic level, and to see how they
respond. As observation of the motions of individual atoms of biomolecules and perturbing them
in a desired fashion is difficult to achieve in real-life experiments, an increasingly attractive
alternative is to work with an atomic-level or coarse-grained molecular dynamics (MD)
simulations of such biomolecules.3
MD simulations tries to predict how every atom in a molecular system will move over time,
based on a general physics model governing interatomic interactions,4 which is known as a
molecular mechanics force field (FF) function.5 These FF functions can be both all-atomistic (AA)
such as Chemistry at Harvard Macromolecular Mechanics (CHARMM)6 FF and Assisted Model
Building with Energy Refinement (AMBER)7 FF or coarse-grained (CG) such as MARTINI8 FF.
MD simulations utilize classical laws of motion to predict the spatial position of each atom as a
function of time.
In last two decades, MD simulations have become substantially more accessible, and they
have increasingly been used to interpret both experimental results and to guide experimental work.
There are two major contributors to wider use of MD. First, technical improvements in field of
1

structural biology have led to an explosion of new structures discovered in the last decade with
significantly improved resolutions, spearheaded by advancements in cryo-electron microscopy
(cryo-EM).9

10

Cryo-EM technique has enabled structure determination of different states of

flexible proteins, but is currently limited to larger proteins with atomic masses greater than
50 kDa.11 Nuclear magnetic resonance (NMR) spectroscopy is also used determine threedimensional model of a protein in solution by obtaining ensemble of structures but NMR is
restricted to smaller proteins with molecular weight of less than 30 kDa.12 A combination of
increasing structural data and limitations of such expensive experimental techniques have lead to
interest in utilizing MD simulations to understand molecular systems.
Secondly, MD simulations have become much more powerful and accessible over the past
decade due to improvements in force field parameters and utilization of powerful graphics
processing units (GPUs)13 to run MD simulations, which has allowed larger and longer simulations
to be run locally at a modest cost.14 15 These advances have allowed atomistic MD simulations of
large macromolecular systems with biological relevance such as entire proteins in solution with
explicit solvent, nucleosomes16 17, virus capsids18 19, ribosomes20 21, among others. MD simulations
can today perform millisecond long simulation of proteins22 or describe models of entire cell
organelle23. Computational limitations of all atomistic simulations are increasingly being
addressed by improving coarse-grained forcefields, which reduces the degrees of freedom and
greatly accelerates MD simulations. Coarse-grained models have been utilized to understand large
scale systems such as membrane proteins, lipid bilayers, nanoparticle aggregates etc.24
In my present work, I have utilized different MD simulation techniques to model nucleic
acids and antiviral mechanisms. In subsequent chapters, I describe: modelling of small single
stranded circular nucleic acids where I highlight key dynamical differences of backbone behavior
in solution between DNA and RNA and ability to capture ions for much longer timescales as
compared with linear nucleic acids; modelling of single stranded DNA corona on carbon nanotubes
(CNT) to quantify the number of nucleotides that cover CNTs, modelling melting mechanisms of
DNA duplexes on laser-excited gold nanoparticles which have potential for drug delivery
2

applications. The next part of my thesis describes projects related to different antiviral
mechanisms. These projects include: building computational models of APOBEC3G protein,
which is known to restrict HIV-1 virus and understanding its interactions with ssDNA; modeling
of broad-spectrum antivirals employing nanoparticles, mimicking heparan sulfate proteoglycans
against human papillomavirus (HPV), in which we identify viral capsid regions that facilitate
binding with such nanoparticles; developing peptide-based therapeutics for fast mutating SARSCoV-2 virus which showcases our innovative adaptive algorithm that generates peptides targeting
against different mutants of SARS-CoV-2.

3

Chapter 2: Methods
All the systems described in this proposal were investigated using atomistic and coarsegrained classical molecular dynamics (MD) simulations. This chapter provides overview of the
principles of MD simulations, force fields involved, parameters used to define interactions
between atoms, coarse-grained beads and the integration method used to solve the equations of
motion for a chosen thermodynamic ensemble.
2.1 CLASSICAL MOLECULAR DYNAMICS
Classical molecular dynamics are based on classical equation of motion using Newton's
equations. Solving Newton’s for a system of N particles gives us time evolving functions of
positions and momenta of particles which is sufficient to completely describe the system. Newton's
equations of motion for a system of N particles are defined as

𝑚𝑖
⃗𝑓𝑖 = −

∂2 ⃗⃗⃗
𝑟1
= ⃗𝑓𝑖
∂𝑡 2

∂
𝑈(𝑟⃗⃗⃗1 , ⃗⃗⃗
𝑟2 , … , ⃗⃗⃗⃗
𝑟𝑁 )
∂𝑟⃗⃗⃗1

where 𝑚𝑖 is mass of particles, ⃗𝑓𝑖 denotes force, 𝑟𝑖 denotes position vectors and 𝑈 is the potential
of the system. To solve one needs to calculate forces ⃗𝑓𝑖 exerted on particle i by all the other particles
present in the system. Assuming that the masses (𝑚𝑖 ) are already known, one needs to define a
potential energy function 𝑈, which is a function of 3N coordinates (𝑟⃗⃗⃗1 , ⃗⃗⃗
𝑟2 , … , ⃗⃗⃗⃗
𝑟𝑁 ) which accurately
takes into account all the possible interactions within the system. Obtaining potential forms
of 𝑈(𝑟⃗⃗⃗1 , ⃗⃗⃗
𝑟2 , … , ⃗⃗⃗⃗
𝑟𝑁 ) and solving the above equations numerically and efficiently are the focal areas
of all MD engines, such as NAnoscale Molecular Dynamics (NAMD)25 and GROningen MAchine
for Chemical Simulations (GROMACS)26. Potential functions are defined as force fields which
approximate interaction of particles through functional form of known simpler potential containing
parameters that may be derived from experiments, quantum calculations, ab initio methods etc.
4

2.2 ATOMISTIC FORCE FIELD
For atomistic force fields, the particles are considered rigid atoms with fixed atomic mass
(m). The parameterization of force fields, for example CHARMM is done through means of
quantum mechanical calculations. The calibration of force field parameters is done by comparing
experimental and simulated thermodynamics properties including heats of vaporization and
solvation free energy, etc.27

28

Force field parameters are divided into two groups, including

bonded (defining intramolecular interactions) and non-bonded (defining intermolecular
interactions) ones. In classical sense, the potential of the system can be consisting of additive
potentials can be categorized as bonded and non-bonded potentials. Consider a full system
potential 𝑉𝑁 = 𝑈(𝑟⃗⃗⃗1, ⃗⃗⃗
𝑟2 , … , ⃗⃗⃗⃗
𝑟𝑁 ) as sum of bonded and non-bonded interaction energies:
𝑉𝑁 = ∑ 𝑉𝑁,𝑏𝑜𝑛𝑑𝑒𝑑 + ∑ 𝑉𝑁,𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑

Bonded potentials (𝑉𝑁,𝑏𝑜𝑛𝑑𝑒𝑑 ) describe intramolecular interactions that includes stretching,
bending and torsions of chemical bonds. Chemical bonds are considered explicitly in molecular
dynamics and are treated as springs which is a minimal description of chemical bonds hence
computationally efficient. 𝑉𝑁,𝑏𝑜𝑛𝑑𝑒𝑑 of CHARMM force field is composed of bond, angle,
dihedral and improper dihedral potentials, as shown in Figure 1, which are explained as follows:
𝑉𝑏𝑜𝑛𝑑 = ∑ 𝑘𝑖𝑏𝑜𝑛𝑑 (𝑟𝑖 − 𝑟0𝑖 )2
𝑏𝑜𝑛𝑑 𝑖

𝑎𝑛𝑔𝑙𝑒

𝑉𝑎𝑛𝑔𝑙𝑒 = ∑ 𝑘𝑖

(θ𝑖 − θ0𝑖 )2

𝑎𝑛𝑔𝑙𝑒 𝑖

𝑉𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙 =

∑

𝑘𝑖𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙 [1 + 𝑐𝑜𝑠(𝑛𝑖 ϕ𝑖 − γ𝑖 )]

𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙 𝑖

5

𝑛𝑖 ≠ 0

𝑉𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟 =

∑

𝑘𝑖𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟 (ϕ𝑖 − γ𝑖 )2 𝑛𝑖 = 0

𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟 𝑖

Above, 𝑉𝑏𝑜𝑛𝑑 , 𝑉𝑎𝑛𝑔𝑙𝑒 and 𝑉𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟 are described by weak harmonic potential forms with spring
𝑎𝑛𝑔𝑙𝑒

constants ( 𝑘𝑖𝑏𝑜𝑛𝑑 , 𝑘𝑖

, 𝑘𝑖𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟 ) and associated instantaneous internal coordinates (𝑟𝑖 ),

angles (θ𝑖 ), dihedrals and improper dihedrals (ϕ𝑖 ), which differ from their equilibrium values (𝑟𝑖 ,
θ𝑖 , γ𝑖 ) in case of external interaction. The equilibrium values r, theta, and gamma represent stable
equilibrium state with minimum stretching, bending and torsional energies. Cosine function is used
to define 𝑉𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙 , which is depends force constant 𝑘𝑖𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙 , periodicity 𝑛𝑖 and dihedrals (ϕ𝑖 )
varying from γ𝑖 .

Figure 1. Pictorial representation of bonded and non-bonded interaction parameters.

Non-bonded potential energies include Coulomb and van der Waals (vdW) potentials,
which are pair-wise interactions. Columbic interactions are calculated using classical coulombs
law for point charges. Coulomb potential between atoms i and j, which carry 𝑞𝑖 and 𝑞𝑗 charges,
respectively is defined as
𝑉𝑐𝑜𝑢𝑙 (𝑟𝑖𝑗 ) = ∑ ∑
𝑖
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𝑗>𝑖

𝑞𝑖 𝑞𝑗
4πϵ0 𝑟𝑖𝑗

Above, ϵ0 and 𝑟𝑖𝑗 denote vacuum permittivity and distance between the center of atoms.
The short-ranged Lennard-Jones (LJ) potential is used to describe van der Waals (vdW)
interactions between atom pair 𝑖 − 𝑗. The Lennard-Jones potential is composed of two terms Pauli repulsion at short ranges due to overlapping electron orbitals and the attractive long-range
term which describes attraction at long ranges (van der Waals force or dispersion force). LJ
potential is defined as
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𝑅𝑚𝑖𝑛,𝑖𝑗
𝑉𝐿𝐽 (𝑟𝑖𝑗 ) = ∑ ∑ 𝜏𝑖𝑗 [(
)
𝑟𝑖𝑗
𝑖

𝑗>𝑖
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𝑅𝑚𝑖𝑛,𝑖𝑗
− 2(
) ]
𝑟𝑖𝑗

where 𝑟𝑖𝑗 is the distance between atoms i and j, and 𝑅𝑚𝑖𝑛,𝑖𝑗 and 𝜏𝑖𝑗 are determined from
the Lorentz-Berthelot:

𝑅𝑚𝑖𝑛,𝑖𝑗 =

𝑅𝑚𝑖𝑛,𝑖 + 𝑅𝑚𝑖𝑛,𝑗
𝜏𝑖𝑗 = √𝜏𝑖 𝜏𝑗
2

where 𝑅𝑚𝑖𝑛,𝑖 , 𝑅𝑚𝑖𝑛,𝑗 and 𝜏𝑖 , 𝜏𝑗 represent the radii and potential well depths of particles i
and j, respectively.
2.3 COARSE GRAINED FORCE FIELD
The use of coarse grained (CG) models has proven to be a valuable tool to probe the time
and length scales of systems beyond what is feasible with traditional all atom (AA) models.29 We
have used MARTINI coarse-grained force field for our research. This model is based on a fourto-one mapping, i.e., on average, four heavy atoms are represented by a single interaction center30
and can be applied on water, lipds, protein, nucleic acids.31 There are four main types of interaction
sites: polar (P), nonpolar (N), apolar (C), and charged (Q). Each particle type has a number of
subtypes, which allow for a more accurate representation of the chemical nature of the underlying
atomic structure. Within a main type, subtypes are either distinguished by a letter denoting the
7

hydrogen-bonding capabilities (d = donor, a = acceptor, da = both, 0 = none), or by a number
indicating the degree of polarity (from 1, low polarity, to 5, high polarity).
Non bonded interactions include short range interactions described by Lennard-Jones
potential and long-range coulombic interaction. These interactions are described by same
mathematical formulation as CHARMM which is also used in many all atomistic force fields.
Bonds and chain stiffness are described by a weak harmonic potential and the mathematical
formulation is same as for all atomistic force field. Dihedral potential described for all atomistic
models is only used to describe ring particles.29
Solvent water is described by a 4 to 1 mapping to coarse grained (CG) particles called P4
particles, and they lead to higher than normal freezing temperature of water. To rectify this
problem, Anti-freeze water particles are introduced (denoted by BP4) for which the LJ parameter
𝜏𝑖𝑗 for BP4−P4 interactions is scaled up. The BP4-BP4 interaction remains the same. Usually, 10%
CG particles of solvent should be anti-freeze water particles.29
2.4 INTEGRATION METHOD FOR MD
The first integral of Newton’s equations of motion provides momenta and second integral
provides space coordinates of the particle. To compute the integrals numerically, velocity-Verlet
integration algorithm is used. For a given particle’s position (Rn), velocity (vn) and force (fn) at
time step (n) the algorithm outputs same values for the next step (Rn+1, vn+1, fn+1). The difference
between the two consecutive steps is small but finite. The velocity-Verlet algorithm is
implemented according to the following steps:

“half-kick”

𝑣𝑛+1⁄2 = 𝑣𝑛 + 𝑚−1 𝑓𝑛 . Δ𝑡/2

“drift”

𝑅𝑛+1 = 𝑅𝑛 + 𝑣𝑛+1⁄2 . Δ𝑡

“compute force”

𝑓𝑛+1 = 𝑓(𝑅𝑛+1 )

“half-kick”

𝑣𝑛+1 = 𝑣𝑛+1⁄2 + 𝑚−1 𝑓𝑛+1 . Δ𝑡/2
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The advantages of the velocity-Verlet algorithm are time reversibility and symplecticity leading
to conserved momentum.
2.5 PERIODIC BOUNDARY CONDITIONS (PBC)
MD simulations have limitations to simulate macroscale systems containing a large number
of atoms (Avogadro’s number) due to large number of degrees of freedom. A finite system will
also have boundary effects that are undesirable in most situations. To resolve these issues, periodic
boundary conditions (PBC) are defined in simulations in three dimensions or two dimensions (slab
boundary condition). Through PBC condition, the original simulation unit cell interacts with its
adjacent periodic images in each direction.
2.6 ENSEMBLES
According to the condition of the experiments, different thermodynamics ensembles can
be applied to implement MD simulations. There are several simulation ensembles, such as NVE
(the number of particles N, volume V and total energy E of the system are held constant), NVT
(N, V and temperature T are held constant), and NPT (N, V, and pressure P are held constant). All
our simulations used NPT ensemble. The coupling of pressure and temperature of the systems are
maintained by using Langevin dynamics method. This method damps T and P fluctuations by
adding a damping and fluctuating terms to the Newton’s equation of motion:

𝑚

𝜕 2𝑟
= 𝑚𝑣̇ = 𝐹(𝑟) − 𝛾𝐿𝑎𝑛𝑔 𝑣 + √2𝛾𝐿𝑎𝑛𝑔 𝑘𝐵 𝑇𝑚 𝐺(𝑡)
𝜕𝑡 2

where r, t, m, v, and F denotes coordinate, time, mass, velocity and force respectively. γLang,
𝑘𝐵 and 𝑇 denote friction factor (depending on the systems and defined by user), Boltzmann
constant and temperature respectively. G(t) denotes a single variable Gaussian process.
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The second and third terms in the equation are damping and fluctuating terms, respectively.
γLang controls the magnitudes of damping and fluctuating terms. For MARTINI simulations,
Parrinello–Rahman system is used for pressure coupling, which is a modified version of Langevin
dynamics.32
2.7 SIMULATION PARAMETERS
All the force fields used in the proposal have non-bonded interaction energies including
both Coulombic (long range) and vdW (short range) potentials. The cut-off distance for vdW
potential energies are explicitly defined to ignore the interaction energies beyond the cut-off
distance. In CHARMM and MARTINI force field, both vdW cut-off distance is usually set to 1.2
nm. Smoothing this potential beyond the cut-off distance is necessary to avoid potential artifacts
due to sharp truncation of vdW potentials. The smoothness occurs between the cut-off distance
and the switching distance (usually 0.8 nm), which is defined by the end user. Coulomb potential
is evaluated for only those atoms whose distances are more than the vdW cut-off distance. Particlemesh Ewald (PME) method33 is used to efficiently calculate the Coulombic electrostatic
interactions in periodic systems. We used explicit solvent (water) molecules, which were modeled
by the TIP3P water model34 for all atomic simulations and MARTINI model for coarse grained
simulations. The time step for integrator is set to 1-2 fs for CHARMM and 20-30 fs for MARTINI.
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Chapter 3 : Structural and dynamical properties of small single stranded circular nucleic
acids
3.1 INTRODUCTION
Nucleic acid biology is presently in a very exciting period: more and more genomic
information has been determined by advanced next-generation sequencing techniques35, properties
of deoxyribonucleic acid (DNA) on molecular and cellular levels are under intense investigation,
and numerous novel ribonucleic acid (RNA) species, RNA functions and RNA targets are being
discovered in living cells. RNA is been used to develop vaccine as a much faster pace.36 Many
new classes of plant and mammals infecting viruses have been found, which have novel genomes
consisting of small single stranded nucleic acids.37 38 Besides DNA and RNA molecules existing
in cells, these molecules have a great potential for use in nanotechnology and biomedical fields.
Progress has been made to incorporate nucleic acids in molecular origami 39, nanoparticles40 and
carbon nanotubes41. Studies are slowly revealing how small RNAs play important role in
regulation of proteins in eukaryotic cells.42 43 44
As an emerging class of nucleic acid molecules with potential biomedical applications, not
much is known about the structural and dynamical properties of circular single-stranded nucleic
acids and constraints that their geometry imposes on these properties. Our goal is to examine these
properties for small single-stranded circular nucleic acids using classical atomistic molecular
dynamics (MD) simulations. Reliable parameters have been determined and validated for atomistic
descriptions of DNA and RNA molecules.45 46
High stability in biological systems is a major criterion for why circular nucleic acids
especially circular RNA (circRNAs) are becoming interesting for RNA-centered medical
applications. Also, circularity is associated also with some other molecular properties that may be
useful for therapeutic purposes.47 Potential applications for circular nucleic acids are summarized
as (a) MicroRNA sponging in competing-endogenous RNAs, including circRNAs, prevents
homologous target mRNAs from degradation or allows their translation.48
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49

(b) Due to stability

of circular nucleic acids, circularization of classically employed linear RNAs is possible because
compared to the rigid dsDNA helix, the flexibility of RNA molecules allows circularization of
even very small RNAs.50 51 (c) In the absence of in-frame stop codons and termination signals, or
after read-through, rolling-circle-translation can occur on circular RNAs which can lead to
translation of multimeric repetitive protein motifs, which could be useful for cell engineering, but
which can become toxic for cells if happening in an uncontrolled fashion.52 53 (d) CircRNAs can
be used as tools to purposefully boost innate immune signaling to counteract disease-induced
immunosuppression.54 55 (e) Circular nucleic acids (both circular ssDNA (circDNA) and circRNA)
can be used for creating aptamers that bind with high specificity which are useful for selective
drug delivery or protein activity control and circularizing them might make them more potent.56
For example, circular DNA aptamer that were targeted against thrombin have half-lives that are
extended beyond 10 h in serum and plasma, making such constructs viable for therapeutic and
diagnostic applications.57 The average half-life of endogenously produced 3′-5′-linked circRNA
was found to amount to 19–24 h58 and can be up to 48 h.59 (f) Lastly, they can serve as a versatile
material for designing and building novel nanodevices such as molecular switches, molecular
motors and walkers.60
For our study, we have constructed several non-base-paired single stranded circular nucleic
acids of varying length and sequence. The purpose of choosing non base-paired sequence is to
understand the dynamics of the backbone of the nucleic acids without interference from paired
bases as they will dominate the structure conformation owing to strong interaction. The sequences
examined include ssDNAs: (GT)n (n=3-24), (C)12, (T)12,(AC)8, and ssRNAs: (GU)n (n=3-24),
(C)12, (U)12, (AC)8. The set of non-base paired circular nucleic acid molecules was relaxed,
solvated in water and simulated for 1 µs in 0.15 M NaCl.
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3.2 METHODS
3.2.1 Building Circular Nucleic Acids
Linear single-stranded DNA and RNA molecules were prepared by 3DNA software61

62

and make-na web server based on B-form of duplex DNA which is the most abundant form.
Circular potential density was obtained from dummy sodium atoms of adjusted diameters
according to the length of the sequence. All linear molecules except (GU)24 and (GT)24 were then
docked with these respective circular potentials using colores (Situs) software 63 with a resolution
of 5 Å.
Molecular dynamics flexible fitting (MDFF) method64 was used force fit these docked
linear molecules into circular shape. In this method, an Electron Microscopy(EM) density map as
a potential so that high density areas in the map correspond to energy minima, so that the atoms in
the structure are subject to forces proportional to the gradient of the EM map. The potential is
defined on a 3-D grid with 3D vector 𝑅 by

𝑈𝐸𝑀 (𝑅) = ∑ 𝜔𝑗 𝑉𝐸𝑀 (𝑟𝑗 )
𝑗

where
Φ(𝑟)−Φ𝑡ℎ𝑟

𝑉𝐸𝑀 (𝑟) = 𝜉 [1 − Φ

] if Φ(𝑟) ≥ Φ𝑡ℎ𝑟

𝑉𝐸𝑀 (𝑟) = 𝜉

if Φ(𝑟) < Φ𝑡ℎ𝑟

𝑚𝑎𝑥 −Φ𝑡ℎ𝑟

Here 𝜔𝑗 corresponds to a per-atom weigh, typically set to the atomic mass, 𝜉 is a force scaling,
Φ(𝑟) is the EM density at position 𝑟, Φ𝑚𝑎𝑥 is the maximum value of the EM density map, and
Φ𝑡ℎ𝑟 is a density threshold. The purpose of the density threshold is to remove from the EM data
the solvent contribution.
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An atom placed in this external potential feels a force of
𝜕
𝑈 (𝑅)
𝜕𝑟𝑖 𝐸𝑀
𝜕
= −𝜔𝑖
𝑉 (𝑟 )
𝜕𝑟𝑖 𝐸𝑀 𝑖

𝑓𝑖𝐸𝑀 = −

MDFF introduces harmonic restraints to preserve the secondary structure of proteins and nucleic
acids where restraints are imposed to seven dihedral angles and two interatomic distances between
base pairs.
In MDFF simulations, our linear nucleic acid molecules were coupled to the density
obtained from dummy atoms arranged in ring shapes. In some of the systems, soft harmonic
potentials were used to fit the linear molecules into the potential. Then, after the linear molecules
were fitted to ring shapes, a covalent bond between the O3′ atom of the last nucleotide and the P
atom of the first nucleotide was created by a patch that we added to the force field, which mimics
the usual nucleotide–nucleotide bond.
3.2.2 Molecular Dynamics simulations
The prepared circular molecules were solvated with TIP3P water and neutralized with 0.15
M NaCl with solvate and ionize VMD plugins, respectively.65 Separately, systems of multiple
(GT)6 circDNAs and (GU)6 circRNAs were simulated in 0.15 M NaCl aqueous solutions; these
molecules were present at either 5.9- or 7.9-mM concentrations. The aqueous solution with
monovalent ions (NaCl) was selected as solvent for simplicity. The systems were described with
CHARMM36 force field parameters.45 MD simulations were performed with the NAMD2.12
package.27 All simulations were conducted with Langevin dynamics (Langevin constant γLang =
1.0 ps–1) in the NpT ensemble, where temperature and pressure remained constant at 310 K and 1
bar, respectively. The particle-mesh Ewald (PME) method was used to calculate the Coulomb
interaction energies, with periodic boundary conditions applied in all directions.33 The time step
was set to 2.0 fs. The evaluation of long-range van der Waals and Coulombic interactions was
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performed every 1- and 2-time steps, respectively. After 2000 steps of minimization, solvent
molecules were equilibrated for 2 ns around the circular molecules, which were restrained by using
harmonic forces with a spring constant of 1 kcal/(mol Å2). Next, the systems were equilibrated in
production MD runs, with center-of-mass (COM) restraints applied to the whole molecule COM
with a force constant of 0.5 kcal/mol, so the molecule remains in the original unit cell.
3.2.3 Data Analysis
Contact Area - To analyze the contact area with the surrounding solvent, the solvent-exposed
fraction of the nitrogenous bases of circular nucleic acids was calculated in time t and defined as
a𝑏𝑎𝑠𝑒 (t) + a𝑤𝑎𝑡𝑒𝑟 (t) − a𝑏𝑎𝑠𝑒 ⋃ 𝑤𝑎𝑡𝑒𝑟 (𝑡)
2
where a𝑏𝑎𝑠𝑒 (t), a𝑤𝑎𝑡𝑒𝑟 (t), and a𝑏𝑎𝑠𝑒 ⋃ 𝑤𝑎𝑡𝑒𝑟 (𝑡) are the solvent accessible surface areas (SASA) of
the bases, water, and bases and water together, respectively. The evaluation was done by the SASA
built-in VMD plugin65, where the van der Waals radius of 1.4 Å was assigned to atoms to identify
the points on a sphere that are accessible to the solvent.
Radial Distribution Function (RDF) - g(r) was calculated for all phosphorus atoms in the circular
nucleotides as a function of time by using g(r) GUI Plugin, v1.3, a built-in VMD plugin.65
Radius of Gyration - The radius of gyration of circular nucleotide chain was evaluated by measure,
2
a built-in VMD plugin,65 as a function of time. The radius of gyration 𝑟𝑔𝑦𝑟
is defined as

𝑛
2
𝑟𝑔𝑦𝑟

= ∑(𝑟(𝑖) − 𝑟̅ )2
𝑖=1

where 𝑟(𝑖) is the position of the 𝑖th atom and 𝑟̅ is the geometric center of the circular nucleic acid.
Ion Residence Times - The residence time, 𝜏𝑟 , is evaluated using a standard time correlation
function 𝑐𝑖 (𝑡) for sodium ion binding to nucleic acid 𝑖:

15

𝐶(𝑡) = ∑ 𝑐𝑖 (𝑡)
𝑖

𝑐𝑖 (𝑡) = ∑ 𝑝𝑖 (𝑡0 )𝑝𝑖 (𝑡0 + 𝑛Δ𝑡)
𝑛

where 𝑝𝑖 (𝑡) is unity if a sodium ion is within 3 Å of backbone of nucleic acid i and zero otherwise,
𝑛 is an integer, and Δ𝑡 is 20 ps. The correlation function calculations were performed for the last
0.8 μs of trajectories. Residence times of hovering ions were calculated by evaluating 𝑐𝑖 (𝑡) over 3
ns long segments of trajectories. Typically, the 𝐶(𝑡) function takes a form of a decaying
exponential:
𝐶(𝑡) ~ exp (−𝑡/𝜏𝑅 )
where 𝜏𝑟 constant represents the residence time. When the ion–nucleic acid binding event occurs
for longer than 3 ns, such ions are considered to be bridged/trapped ions. These binding events
have much longer residence times and do not behave as a decaying exponential function, as these
events are stochastic and rare for the time scale of the simulations performed.
3.3 RESULTS
3.3.1 Conformations of Circular Nucleic Acids in Aqueous Solution.

Figure 2. Conformations of (a) circDNA-(GT)n and (b) circRNA-(GU)n at 0 μs (red), 0.5 μs
(white), and 1 μs (blue) as observed in MD simulations. The scale bars for n = 3, 4, 6, and 8 are 1
Å in length, and the scale bar for n = 24 is 10 Å in length.
In Figure 2, three representative structures of circDNA-(GT)n and circRNA-(GU)n molecules with
n = 3, 4, 6, 8, and 24 are shown after 0, 0.5, and 1 μs of equilibration. Structures of the smallest
circNAs, 6 and 8 nts in length, remained similar to the initial structures, as they experience the
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largest steric strain due to covalently bonded ends. For these smallest circNAs, limited refolding
was observed, as the molecules sought the optimal placement of negatively charged backbones,
while protecting the hydrophobic bases from contact with water. circNAs with a larger number of
nucleotides, 12–48 nts, refolded significantly during the course of trajectories, as they sought more
energetically favorable conformations. Equilibrated structures (blue) in Figure 2 indicate that
backbones of circDNA-(GT)n are more likely to be bent than backbones of circRNA-(GU)n. Also,
backbones of circDNAs of intermediate lengths (12–16 nts) are more likely to have sharp kinks
than the backbones of circRNAs.
Backbone flexibility of the molecules studied was analyzed by calculating the angles
between phosphorus (P) atoms of three neighboring phosphate groups, averaged over all triplets
of P atoms on neighboring nucleotides and over time (inset of Figure 3).
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Figure 3. Phosphate angles in the nucleic acids examined, averaged over all P atom triplets and
over the last 500 ns of trajectories.
The calculated average angles, shown in Figure 3, are consistently smaller in circDNA than in
circRNA. The average angles of three consecutive P atoms in circDNAs range from 100° to 118°,
while these angles in circRNAs range from 105° to 135°. For all circNAs, except for the shortest
and the most sterically strained 6-nt circles, the distributions of the angle values (fluctuations) are
also always wider (larger) for circDNAs than for circRNAs, as observed in Figure 3. The values
of the measured angles and the comparative fluctuations of these angles indicate that circDNA
backbones favor more bent structures (smaller angles) and are less rigid than circRNA backbones.
The trends observed for (GT)n/(GU)n molecules are confirmed for other circDNAs ((AC)8, (C)16,
(T)16) and circRNAs ((AC)8, (C)16, (U)16) sequences, as shown in Figure 3. The trends observed
here for circular nucleic acids are consistent with previous experimental observations for linear
single-stranded nucleic acids, where end-to-end FRET measurements showed that (T)40 ssDNA is
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more flexible and has shorter persistence length than (U)40 ssRNA.64 However, recent atomistic
and coarse-grained simulations demonstrate the opposite behavior of ssRNA and ssDNA for the
selected simulation parameters and force fields.66 Because elasticity and flexibility of singlestranded nucleic acids have great sensitivity to nucleotide sequence and whether base pairing is
possible, salt species, and salt concentrations in the solution67 68, more detailed studies are required
to examine whether our observations, which agree with experimental observations as reported, are
general.
3.3.2 Positioning of Phosphates, Sugars, and Bases in Circular Nucleic Acids
Binding of circNAs to other molecules can occur via different interactions, including
Coulomb, hydrophobic, and hydrogen-bonding interactions. The phosphate groups of circNAs
should play a key role in their Coulomb interactions. Because conformations of circDNAs and
circRNAs are different (Figure 2), the positioning of their phosphate groups and negative charge
densities should be different as well.

The arrangement of phosphate groups in circNA molecules is analyzed in the form of radial
distribution functions (RDFs) of P atoms on phosphate backbones of circNAs, as shown in Figure
4.

19

Figure 4. Radial distribution functions (RDFs) of phosphorous atoms of circNAs calculated over
1μs in MD simulations. RDFs are computed with a 10 ns time step. (GU)n circRNAs have Patoms that are more likely to be closer to each other than P-atoms of (GT)n circDNAs, for all
circNAs examined.
Consistently, RDFs have peaks at smaller P–P distances in circRNAs than in circDNAs. The
probability to observe P–P distances less than 5 Å is significant for circRNAs but is noticeably
smaller in circDNAs. Na+ ions are often found in the solvation shell of phosphate ions but can also
bridge the backbones of circNAs, bringing close together the phosphate groups (either neighboring
or non-neighboring). The circRNA-(GU)n molecules with n < 24 have a larger average number of
Na+ counterions present at close distances than circDNA-(GT)n molecules, as shown in Figure 5a,
likely because of the more hydrophilic nature of an additional 2′-OH group on the RNA phosphate
backbone. circRNA-(GU)n molecules are observed to have 0.4–1.3 more Na+ ions per molecule
than circDNA-(GT)n molecules.
Next, the behavior of the hydrophobic bases of circNAs was examined. As in all nucleic
acids, the bases in circNA molecules often exhibit stacking. Non-neighboring bases can also form
hydrogen bonds but not base pair, due to the choice of non-base-pairing sequences in this study.
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Besides stacking, bases in circNA molecules are also partly exposed to water due to the circular
geometry and the flexibility of these molecules. Figure 5d show the areas of nucleotide bases
exposed to the aqueous solution (water).

Figure 5. (a, b) Average number of sodium ions within 4 Å of nucleic acids examined, averaged
over the last 500 ns of 1 μs MD trajectories. (c) Conformations of small circNAs with
bridged/trapped sodium ions that have the longest residence times (Table 1). Polar atoms (P, O,
and N) of nucleic acids within 3 Å of Na+ ions are highlighted as vdW spheres. (d) Contact areas
between nucleotide bases and aqueous solvent for circNAs observed in MD simulations,
averaged over the last 500 ns of 1 μs simulations. (e) Average radii of gyration of different parts
of nucleotides (bases, sugars, and phosphate groups), averaged over the last 500 ns of 1 μs
simulations.
circDNA bases are consistently (10–25%) more exposed to the aqueous solution than
circRNA bases for molecules of different lengths and sequences. The exposure of bases to the
solvent is affected by the folded arrangement of circNAs. Figure 5e shows the relative positioning
of base, sugar, and phosphate groups in the circNAs examined in the form of the average radii of
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gyration of these groups, Rgyr, i.e., the average distances of geometric centers of these groups from
geometric centers of circNA molecules. Consistently, in circDNAs, the bases have significantly
larger Rgyr than phosphate groups (by 1–2 Å). Therefore, in circDNAs, phosphate groups are likely
to be positioned closer to COMs of the circular molecules, and the bases are more likely to be
further away from COMs. In circRNAs, the situation is similar for the smallest circRNA, (GU)3.
However, for (GU)n, with n = 4, 6, 8, and 24, the bases and phosphate groups either have similar
Rgyr or the bases have smaller Rgyr than the phosphate groups. Therefore, bases are either closer or
at similar distances to geometric centers of circRNA molecules, in comparison to the phosphate
groups. The observed trends are also confirmed by the visual analysis of representative circDNA(GT)6 and circRNA-(GU)6 molecules in Figure 8a, which clearly shows that the backbone of
circDNA is accommodated within the folded structure, whereas the circRNA backbone is found
more on the outside of the molecule.

Figure 6. Comparison of circular and linear oligonucleotides. (a) Representative snapshots of
circular and linear (GT)6 and (GU)6 DNA and RNA molecules. (b) End-to-end distance (O5T
atom of the first nucleotide and O3′ atom of the last nucleotide) observed in 1 μs MD simulations
of linear (GT)6 DNA and (GU)6 RNA molecules.
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3.3.3 Comparison of Circular and Linear Oligonucleotides
The key difference between circular and linear molecules is the covalent bonding between
3′- and 5′-end nucleotides. In circular molecules, the 3′- and 5′-end nucleotides remain stably
bound to each other. However, the distance between end nucleotides of linear molecules examined
for (GT)6 and (GU)6, fluctuates between <0.5 and 6 nm (Figure 6b). Therefore, covalent bonding
clearly presents a significant geometric constraint within flexible nucleic acid molecules without
base pairing. Both linear and circular DNAs are found to be more bent and less rigid than the
corresponding RNA molecules. However, circular RNA has a significantly more bent backbone
than linear RNA, as its P–P–P angles assume on average 120° in comparison to 140° that the P–
P–P angle of linear (GU)6 assumes on average (Figure 3).
Negatively charged backbones of circNAs encircle the space within these molecules. Given
the circular arrangement of the negative charge in circular molecules versus a more disordered
arrangement of the negative charge in linear molecules, the number and coordination of
counterions may be different for circular and linear molecules. In fact, Figure 5b shows that
circular (GT)6 and (GU)6 molecules have on average a greater number (1–1.5) of sodium
counterions within 4 Å of these molecules than their linear counterparts and are thus more effective
at sequestering counterions.
Table 1. Three Longest Residence Times of Na+ Ions Stably Binding in Pockets of Circular and
Linear (GT)n and (GU)n Molecules, Reported in nanoseconds.
Circular

Linear

(GT)3 (GU)3 (GT)4 (GU)4 (GT)6 (GU)6 (GT)8 (GU)8 (GT)24 (GU)24 (GT)6 (GU)6
320

180

410

387

95

443

307

215

800

757

27

73

176

156

188

77

68

223

68

41

539

479

26

49

162

74

83

74

57

75

59

35

459

339

18
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In both circular and linear molecules, counterions either can be hovering or can assume
bridging/trapped conformations. Figure 5c shows that small circular nucleic acids can form stable
pockets for counterions, which can remain for hundreds of nanoseconds, as shown in Table 1. The
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smallest circular nucleic acids seem to form especially interesting ion pockets, resembling crown
ethers. While the trapped ions remain bound to circular (GT)6 and (GU)6 molecules for up to ≈95
and ≈443 ns, they remain bound to analogous linear molecules for significantly shorter times of
up to ≈27 and ≈57 ns. We note that the measurements of single ion residence time are stochastic,
where obtaining better statistics would require significantly better sampling of long binding events
between ions and nucleic acids. While the geometry of the smallest circular nucleic acids can lead
to ion sequestration via the existence of preformed pockets (Figure 5c), small linear single stranded
molecules have also been observed to bend and fold around ion69 70, and ion binding is generally
known to determine the tertiary structures and folding of ssRNAs.71
3.3.4 Circular Nucleic Acids at Millimolar Concentrations
Besides examining the interactions of circNA molecules with Na+ counterions, we also
explored the behavior of multiple circNA molecules in 0.15 M NaCl solution. Solutions containing
three/four circDNA-(GT)6 or three/four circRNA-(GU)6 molecules were prepared at
concentrations of 5.9 mM/7.9 mM and allowed to equilibrate for 1 μs. After 1 μs, three out of four
circDNA-(GT)6 molecules aggregated, while one molecule diffused in the solution. On the other
hand, all four circRNA-(GU)6 molecules aggregated. In the aggregated states, the molecules
formed chains, as shown in Figure 7, rather than globular aggregates.
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Figure 7. Circular nucleic acids at 7.9 mM. Four circDNA-(GT)6 (a) and circRNA-(GU)6
molecules (b) after 1 μs of equilibration.
Such chain formation, due to repulsion between negatively charged circDNA molecules, was
observed for other negatively charged moieties, such as nanoparticles coated with negatively
charged ligands72. Interestingly, the aggregation of circular molecules affects their phosphate angle
distributions very likely because aggregated molecules adopt different conformations from single
solvated molecules; the aggregated molecules have different solvation and can engage in
intermolecular stacking. While circNAs are observed to aggregate at 7.9 mM concentrations, such
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aggregated states should be unfavorable or transient at concentrations at which small nucleic acid
molecules, such as aptamers, are used in applications (nanomolar)57. The aggregated states are
unlikely at low concentrations because translational entropy of separated molecules should
overcome the favorable enthalpies of binding. In fact, even at 7.9 mM concentration, dissociation
events are observed for circNAs.
3.4 CONCLUSION
In summary, we examined small covalently closed single-stranded circular DNAs and
RNAs in microsecond long MD simulations. circDNAs were found to be more bent and more
flexible than circRNAs. These molecules have distinctly different backbone and base
arrangements in the observed conformations. Small circular nucleic acids are observed to be more
effective in sequestering counterions than linear nucleic acids of same sequence and length, in
conformations that resemble crown ethers for the smallest molecules examined. While the
exposure of bases to aqueous solvent was more pronounced in circDNAs than in circRNAs,
circRNAs were more prone to aggregation at millimolar concentrations. The dynamics, folding,
three-dimensional structures, and finally biological/technological functions of circular nucleic
acids are therefore expected to be dependent on molecular flexibility, ionic species, and ionic
concentrations present, in analogy to linear single-stranded nucleic acids.66

73 74

These circular

molecules, expected to have slow degradation in cellular environments, are expected to be
promising new constructs for therapeutic, diagnostic, and nanotechnology applications.
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Chapter 4: Understanding melting mechanisms of DNA on laser-excited gold nanoparticles
4.1 INTRODUCTION
Structure and function of biological materials is highly sensitive to local temperature.
Modulation of the local temperature around biological materials can provide for precise control
over both biological structure and activity.75 One way is to utilize plasmonic nanoparticles (NPs)
which have emerged as remote-controlled light-activated heat sources. Such NPs can be readily
coupled to biological materials in order to control temperature.76 Such photothermal heating
systems can be designed to control the solution temperatures at nanometer length ranges allowing
for applications such as photothermal therapy77, molecular hyperthermia78, and gene therapy79.
Recently, it has been shown that femtosecond laser pulsed excitation of plasmonic NPs can
generate local temperature increases that are capable of controlling the activity of biomolecules
scaffolded on the NP surface.80 81 The increase in initial temperature around the NP can be tuned
to the biologically relevant temperature range and the nanosecond duration of the temperature
increase and steep temperature gradient extending from the NP surface create a highly dynamic
temperature profile for biological materials.
Plasmonic NPs such as gold nanoparticles (AuNPs) can readily be conjugated with
biological materials.82

83

AuNPs to act as an optically controlled heat source in biological

applications such as photothermal therapy,84 85 membrane potential actuation,86 87 and molecular
release/delivery.88

89

Previous theoretical work suggests design of photothermal systems using

AuNPs that can be used to generate controlled temperature profiles relevant to biological activity.90
Although continuous wave (CW) excitation leads to a steady-state temperature profile
characterized by a 1/radius (r) temperature dependence, femtosecond (fs) laser pulse excitation can
generate a temperature profile around a AuNP that follows a 1/r3 temperature dependence91 leading
to generation of temperature profiles that are temporally and spatially confined to the nanoscale.90
91 92
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Ultrashort pulses of light can be used to release of nucleic acids from the surface of AuNPs
which has shown to optically trigger nucleic acid release both in vitro and in vivo.93 94 Recently,
Dr Igor Medintz and Dr Sebastian Diaz at Naval Research Laboratory (NRL), our collaborators
on the present project, developed a quantitative local nanothermometer to understand the level of
control afforded over denaturation of dsDNA displayed on gold nanoparticles (AuNP) under fslaser pulsed excitation.92 They used a modified dissociation equation to calculate a “sensed”
temperature felted by dsDNA and compared to the theoretical average temperature.95 Typically,
the “sensed” temperature was found to be greater than theoretical average temperature, indicating
that local peak or maximum temperatures play a significant role in the denaturing process.
In this work, we have utilized MD simulations to understand melting mechanisms of
dsDNA after a single fs laser pulse excitation of dsDNA conjugated AuNP. We have simulated 19
and 13 base-pair long dsDNA attached to a 3T (Thymine) spacer ssDNA, which is in turn attached
to an alkane chain linker. This alkane linker is covalently bonded to gold surface via gold-thiol
bond. We carried out simulations at room temperatures, elevated temperatures and under a single
laser pulse of energy fluences of 14.1 J/m2 by mimicking heat profiles extracted from modified
dissociation equation containing “sensed” DNA temperature. Our work shows that melting
mechanism depends on length of dsDNA, orientation of relaxed dsDNA, intensity of the laser
pulse, proximity to gold surface and bulk solution temperatures. In our simulations, we observe
that dehybridization of dsDNA (≥ 50% base-pair broken), which leads to subsequent release of
single DNA strand in solution, is a rare event. We also observe that proximity to gold surface
promotes melting of dsDNA. Thus, shorter dsDNA and increased proximity of relaxed dsDNA to
the gold surface prior to laser pulse make them more susceptible for dehybridization.
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4.2 METHODS
4.2.1 Building dsDNA conjugated to gold surface.
Structure of gold atoms arranged in face centered cube (fcc) lattice was directly obtained
from Crystallography Open Database (COD)96 and was cut to design gold layer consisting of three
layers of atoms along (1,1,1) direction using MERCURY CSD 2.0 software.97 The bottom gold
layer was heated to mimic laser pulse. The alkane linker was build using AMPAC 8.0 software98
and was covalently bonded to gold surface with gold-thiol bond. The other end of the linker was
covalently bonded to ssDNA spacer (3T) which is linked to dsDNA. All initial DNA structures
were build using 3DNA software.62 Two DNA sequences one longer 19 base-pair (3’TCTCTACCTACTCACCTCA-5’) and one shorter 13 base-pairs (3’-TCTCTACCTACTC-5’)
were tested in this work. An identical layer of gold surface was placed on top the simulation box
after minimization such that there is a vacuum gap between gold layer of adjacent periodic cells
along z-axis. The system was solvated with TIP3P water with desired ion concentrations between
these two gold layers. The top gold layer ensures that during simulations, the water in the system
remains in liquid phase (no vaporization) and no heat is propagated to periodic cells along z-axis
due the presence of vacuum layer.
4.2.2 Mimicking Single Laser Pulse to heat Gold Surface
The 13-bp systems in aqueous solution in between two gold layers and equilibrated at 22°C
as described above were used as the starting points for non-equilibrium MD simulations. The nonequilibrium simulations examine the effects of the nonhomogeneous heat pulses in the system. To
mimic the localized heating induced in the gold nanoparticle by short laser pulses with 14.1 J/m 2
and 20 J/m2 energy fluences, we applied oscillatory force, 𝐹𝑧ℎ , on all atoms of the bottom gold
layer under the DNA construct along the z-axis:
𝐹𝑧ℎ = 𝐴𝑠𝑖𝑛𝜔𝑡
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where 𝐴 and 𝜔 are constant parameters that are optimized to mimic the local temperature profile
obtained from the modified dissociation equation. Force 𝐹𝑧ℎ was applied for 20 ps, leading to the
local heating of the gold atoms, with γLang = 1.0 ps–1. The cooling temperature profiles in MD
simulations are then generated by applying oscillatory decaying force 𝐹𝑧𝑐 along z-axis to all the
gold atoms of the bottom gold layer surface for the next 2 ns:
𝐹𝑧𝑐 = 𝐴𝑖 𝑒 −𝑀𝐷𝑡 𝑠𝑖𝑛𝜔𝑡
where decay factor D depends on boundary conditions at t = 0 and t = 2 ns such that
𝐷=

1
𝐴𝑖
𝑙𝑛
𝑀𝑇 𝐴𝑓

where 𝐴𝑖 is the amplitude at initial time (t = 0) and 𝐴𝑓 is the amplitude at final time (t = 2 ns). The
value of 𝐴𝑖 and 𝐴𝑓 are chosen such that the cooling profile of water mimic the profile obtained
from the modified dissociation equation. 𝑀 is a constant number which modulates the decay
function and 𝑇 is the total number of timesteps in a 2 ns long simulation. All three parameters 𝐴𝑖 ,
𝐴𝑓 and 𝑀 are constant numbers that are optimized to mimic the cooling profiles. The constant 𝜔

has the same constant value as in during heating. The parameters to mimic in MD simulations the
effects of two laser pulses with 14.1 J/m2 and 20 J/m2 energy fluences are provided in Table 2.
Force 𝐹𝑧𝑐 was applied for 2 ns, with γLang = 0.01 ps–1. After 2 ns, application of force to the gold
layer was removed, and the systems were allowed to relax for 100 ns, using γLang = 0.0005 ps–1. In
all cases and at all steps, atoms of the gold layer were restrained using harmonic potential with a
spring constant of 1 kcal/(mol Å2). cooling.
During the non-equilibrium simulations, the presence of the top gold layer ensures that the
water in the system remains in the liquid phase (no vaporization) and that no heat is propagated
along the z-axis between the periodic cells due to the presence of the vacuum layer.
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Table 2. Optimized force parameter for heating and cooling under laser pulse
Pulse intensity

Heating

Cooling

𝐴 (kcal/mol Å2)

𝜔 (fs-1)

𝐴𝑖 (kcal/mol Å2)

𝐴𝑓 (kcal/mol Å2)

𝑀

14.1 J/m2

31.0

0.0225

8.0

2.1

1.1

20 J/m2

40.0

0.0225

9.0

3.0

1.0

4.2.3 Molecular Dynamics simulations
The prepared systems were solvated with TIP3P water34 and neutralized with 0.25 M NaCl
and 0.05 M MgCl2 to mimic ionic concentration of HEPES (4-(2-hydroxyethyl)-1piperazineethanesulfonic acid) buffer and Mg2+ used in experimental setup with solvate and ionize
VMD plugins, respectively.65 All systems were described with CHARMM36 force field
parameters.45 MD simulations were performed with the NAMD2.13 package.27 Initial systems
were built without placing the top gold layer. These systems were minimized for 5000 steps and
after that the solvent were equilibrated around solute progressively, first, for 0.005 ns with timestep
set to 1.0 fs and cutoff electrostatics, followed by 0.01 ns long relaxation with full electrostatics
with timestep set to 1.0 fs. The systems are further relaxed for 0.075 ns with timestep set to 1.5 fs
and then finally for 2 ns with timestep of 2.0 fs.
After equilibrations, the top gold layer was placed, and after that all systems where further
minimized for 5000 steps and 2 ns long equilibration of solvent around the solute. For all the
systems. All the systems were then equilibrated for 100 ns at room temperature (295 K) to allow
DNA relaxation with Langevin dynamics (Langevin constant γLang = 1.0 ps–1) in the NPT
ensemble, where temperature and pressure remained constant at 310 K and 1 bar, respectively. The
particle-mesh Ewald (PME) method was used to calculate the Coulomb interaction energies, with
periodic boundary conditions applied in all directions.33
The relaxed DNA was utilized for production MD runs which were 100 ns long including
triplicates of MD runs at elevated temperatures (360 K), with and without gold layer. The relaxed
DNA structures were utilized to simulate laser pulse involving 20 ps heating with force 𝐹𝑧ℎ applied
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to bottom gold layer at γLang = 1.0 ps–1 followed by cooling for 2 ns cooling with force 𝐹𝑧𝑐 applied
to bottom gold layer at γLang = 0.01 ps–1 and finally relaxed for 100 ns at γLang = 0.0005 ps–1. In all
cases and at every step, the gold layer was restrained using harmonic potential with a spring
constant of 1 kcal/(mol Å2).
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4.3 RESULTS
4.3.1 Effect of presence of gold layer

Figure 8. Dynamics of 19 nucleotide long dsDNA - (a) Initial structure of dsDNA with and
without gold layer. Gold atoms are denoted by yellow beads. (b) dsDNA after 100 ns long
simulation at 295 K. (c) Schematic diagram six membered ring of nitrogenous base which are
involved in formation of base pair with bond lengths. (d-f, top) Heat maps of distance (D)
between the base-pairs for three trials of 100 ns long simulations at 360 K with gold layer. Cyan
colored regions indicate intact base pairs. Base-pairs broken at 100 ns are highlighted in red on
right hand side of respective heat map, (d-f, bottom) Snapshots of DNA on gold surface at 100
ns. (g-i) Same as panel (d-f) except without gold layer.
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DNA interacts strongly with and facilitates melting of dsDNA from the bottom. After 100
ns of relaxation at 295 K (room temperature), the 19 nucleotide long DNA prefers to tilt and
interact with gold surface, which leads to some helix distortion and breakage of bottom most base
pair (T-A) (Figure 8b, top), whereas in case of the system without gold layer, DNA retains its
initial structure without any significant distortion of the DNA helix as shown in Figure 8b, bottom.
No base-pairs are broken in absence of gold layer at 295 K. Interaction with gold layer is very
stable over the course of trajectory as DNA does not prefers to move once its relaxed on the gold
surface.
To measure time evolution of base-pair breaking, we analyzed heat map of distance (D),
measured at fixed time interval over the course of the trajectory as shown in Figure 8(d-i). D is
defined as distance between the geometric center of 6 membered ring of nitrogenous base which
are involved in hydrogen bonds leading to formation of base pair (Figure 8c). Based on previous
work by Guerra et al, the estimated value of D is 5.56 Å for A-T base pair and 5.65 Å G-C base
pair.99 Thus, regions in cyan color in the heatmap refer to the intact base-pairs of the duplex DNA
(Figure 8(d-i)).
At 360 K and in presence of gold layer we see significant melting from both top and bottom
as shown in three trials in figure 8(d-f). Trial 2 (figure 8e) show minimal melting from the bottom
unlike trial 3 (figure 8f) which captures the rare event of DNA dehybridization (≥50 % of basepairs are melted). This indicates that melting of dsDNA depends on its orientation with respect to
the gold surface. In all three trials, we observe that DNA can “lay down” on gold surface which
facilitate the melting process by disrupting the helical structure of dsDNA. Absence of gold layer,
as shown in three trials in figure 8(g-i), show significantly less melting on average as compared to
with gold layer trials. As no gold layer is present, the helical structure remains intact except for
broken base-pair regions. We do not observe any DNA dehybridization in 100 ns long simulation
in absence of gold layer.
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4.3.2 Melting mechanism due single laser pulse.

Figure 9. Dynamics of 13 nucleotide long dsDNA under a laser pulse - (a) Initial structure of
dsDNA. Gold atoms are denoted by yellow beads. (b) dsDNA after 100 ns long simulation at 295
K. (c) Average solvent temperature in MD simulations (lines) compared with theoretical
temperature profile (dots). z represents distance from gold layer. Vertical green line denotes the
time when heating was stopped. (d-f, top) Heat maps of distance (D) between the base-pairs for
three trials of 102 ns long simulations after heating by a laser pulse of intensity 14 J/m2 . Cyan
colored regions indicate intact base pairs. Base-pairs broken at 100 ns are highlighted in red on
right hand side of respective heat map, (d-f, bottom) Snapshots of DNA on gold surface at 100
ns. (g-i) Same as panel (d-f) except simulating at 322 K instead of heating the gold layer with a
laser pulse.
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We utilized shorter 13 nucleotide long base pair to study melting mechanism under a single
pulse of laser of intensity 14J/m2. Figure 9b shows at after relaxation of 100 ns at 295 K, the DNA
“lays down” on the gold surface with bottom most base pairs broken at 100 ns. The shorter DNA
interacts significantly more with the gold layer allowing almost entire duplex to lay horizontal on
the gold surface. This orientation of relaxed DNA is also observed albeit to less degree in longer
DNA (figure 8b, top). Such orientation makes DNA more susceptible to melting under laser pulse
as it increases the proximity of base-pairs to the gold layer allowing access to solvent regions that
will have higher local temperatures during heating and subsequent cooling under laser pulse.
As shown in figure 9c, we measured average temperature of solvent close to gold surface
(0 < z < 10 Å) and far away from gold surface (105 < z < 110 Å) in MD simulations. These
measurements were consistent with theoretical local temperature profiles showing that water close
to the gold surface is quickly rises to 425 K due to laser pulse and falls rapidly due to heat
dissipation in bulk solution. Solvent far away from the solution do not see such step rise in
temperature which peaks at around 350 K as compared with water close to the gold surface (figure
9c). The difference in temperature profiles of solvents in both regions confirm the highly localized
nature heating by fs pulsed laser. These temperature profiles indicate that dsDNA is exposed to
very high temperatures for short period of time which can induce melting and eventual
dehybridization of dsDNA and proximity to gold surface during laser pulse should facilitate DNA
melting.
Figure 9(d-f) shows results for three trials of 100 ns relaxation after laser pulse of 14 J/m2
intensity. In all three trials, we observe that base-pair breaking is not a spontaneous event in
response to the heating due to laser pulse. In trial 1, we observe minimal melting from the top as
compared with other two trials due to fact that the upper portion of the dsDNA is farther away
from gold surface than in other two trials indicating the positive role of gold layer on DNA melting
(figure 9d). Dehybridization of DNA, which is a rare event, is only observed in trial 1. In such
events, DNA start smelting significantly from one end at around 50 ns and progressively increases
to cause dehybridization of duplex DNA (figure 9d). Additional simulations mimicking the
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localized heating of the gold nanoparticle by a laser pulse with 20 J/m2 energy fluency demonstrate
immediate effects on dsDNA duplex stability, where breaking of base pair nucleotides at the
duplex end closer to the Au-S bond is observed within the first few nanoseconds after the pulsed
heating.
Our collaborators at NRL lab, based on their theoretical model, estimated that the melting
effect of dsDNA under single laser pulse of 14 J/m2 will be similar if, instead of laser pulse, the
average temperature of the bulk solution is kept at 322 K. Figure 9(g-i) shows melting of DNA in
three trials of 100 ns long simulations at 322 K. The melting of dsDNA at 322 K is very similar to
melting under laser pulse of intensity of 14 J/m2 validating the theoretical model. Such models can
utilize to calculate local “average sensed” temperature parameter which can provide better
understanding of actual biological responses in such systems and allow researchers to design
precision nanoscale photothermal heating sources.
4.4 CONCLUSION
MD simulations can be utilized to simulate melting mechanisms of dsDNA bound to
AuNPs due to femtosecond pulsed laser, with excellent agreement with both theory and
experiments. Our innovative approach can be applied to similar systems involving heating by
pulsed lasers. Our work demonstrates that dsDNA melting under fs pulsed laser is an uncommon
event which does not happen spontaneously after heating by laser pulse. The melting mechanism
does not have any preferred ends of the dsDNA but proximity to gold surface seems to facilitate
DNA melting. MD simulations validated the local “averaged sensed” temperature felt by the DNA
calculated using theoretical model involving dissociation equation for DNA. Accurate knowledge
of such parameters can be used to design better heat sources for such plasmonic NP systems.
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Chapter 5: Realistic modeling of ssDNA corona on Carbon Nanotubes (CNTs)
5.1 INTRODUCTION
Functional nanomaterials are often hybrid materials consisting of a solid core material and
an organic interface that guarantees colloidal stability and functionality. Therefore, the properties
of such hybrid materials are more complex than those of bulk materials. Single-walled carbon
nanotubes (SWCNTs) are a highly interesting building block for functional nanomaterials such as
biosensors, drug delivery agents, and optoelectronic devices.

100 101

Semiconducting SWCNTs

fluoresce in the near-infrared (nIR), which is a useful property for optical applications such as
imaging, biosensing, or optoelectronic applications.102

103

However, SWCNTs are hydrophobic,

and therefore, different concepts have been developed to ensure water solubility and colloidal
stability.104

105

One of the most common noncovalent functionalization approaches uses single

stranded DNA (ssDNA). ssDNA functionalization has been extremely successful in separation of
different chiralities of SWCNTs.106 107 Therefore, the interface between ssDNA and SWCNTs is
of special interest. One of the basic metrics of ssDNA/SWCNT conjugates is the number of ssDNA
molecules per SWCNT, or in other words, the SWCNT segment length one ssDNA molecule
occupies. Reported numbers vary, for example, for (GT)16, from ∼6 nm (adsorbed DNA train
length) to 16−20 nm.108

109

Additionally, the length of one ssDNA pitch at the SWCNT surface

has been reported to differ from ∼2 to ∼14 nm up to 20 nm.110 111
SWCNTs are versatile building blocks for optical sensors.101 Molecular recognition is
essential for sensing, and therefore, various (noncovalent) functionalization concepts have been
used with different macromolecules. These conjugates have shown to be very successful for
sensors including neurotransmitters such as dopamine, proteins, and small molecules.112 113 Again,
ssDNA functionalization has served as a key concept. The recognition and photophysical
mechanism has been attributed on the one side to conformation changes that varies exciton decay
pathways.114 On the other side, the influence of redox chemistry has been discussed.115

116

Interestingly, it was shown that for sensors of the important neurotransmitter dopamine, sequence
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and length affect sensitivity and also selectivity.117 In this context, the ssDNA wrapping and the
design of an organic corona have been discussed as a guide to create general recognition motifs.
The exact coverage, conformation, and dynamics of ssDNA on SWCNTs should play an important
role, especially in light of recent simulations that show the importance of kinetics (rate constants)
for sensing and imaging with such sensors.118
Even though ssDNA functionalization of SWCNTs is widely used, many fundamental
aspects of the ssDNA phase around SWCNTs are still unclear. Most importantly, quantitative data
regarding the adsorption of ssDNA are not fully available. Therefore, the simple question how
many ssDNA molecules are bound to a single SWCNT has not been fully addressed.
Here, we determine conformations of ssDNA molecules present on CNT surface in
experimentally determined number densities. The number densities were determined by our
collaborator, S. Krauss, as reported in Ref 101.
5.2 METHODS
5.2.1 Molecular Dynamics simulations
We used classical atomistic MD simulations to examine the structure of (GT)15
ssDNA/(6,5)-SWCNT conjugates. We determined the likely structures of these conjugates and
calculated the contact areas between ssDNA and SWCNTs. The simulated systems contained
(6,5)-SWCNTs wrapped with (GT)15. The initial configurations of all simulations were generated
by using Material Studio (Accelrys Software Inc. Materials Studio, Release 4.5; Accelrys Software
Inc.: San Diego, CA, 2007) and VMD software.65 First, a helical structure of (GT)15 ssDNA was
constructed by using Material Studio. Then, a (6,5)-SWCNT was wrapped by the helical ssDNA
by using VMD plugins. The systems were solvated and ionized by solvate and ionize VMD
plugins, respectively;65 the salt concentration of 150 mM NaCl was selected to mimic
physiological conditions. The final systems contained approximately 29,725 atoms.
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The CHARMM36 force-field parameters119 and TIP3P water model were used to define
interactions for all the simulated molecules.6 MD simulations were performed with NAMD2.12.25
Long-range electrostatics were evaluated by the particle-mesh Ewald method.33 The evaluation of
van der Waals and long-range Coulomb interactions was performed every 1 and 2 time steps,
respectively; the time step was set to 2 fs. All the simulations were conducted in the NpT ensemble
and with periodic boundary conditions applied. Temperature and pressure remained constant at
310 K and 1 bar, respectively; the Langevin constant was set to γLang = 1.0 ps–1. The first prepared
system, containing the (6,5)-SWCNT wrapped by a helically arranged (GT)15, was initially
minimized for 10,000 steps. After minimization and warming the system, water and ions were
equilibrated for 2 ns around the hybrid systems, which were restrained using harmonic forces with
a spring constant of 1 kcal/(mol Å2). Then, the system was equilibrated for 100 ns, while only
SWCNT atoms were held restrained. The second system was simulated to examine the structure
of a (GT)15 molecule wrapping (6,5)-SWCNTs, while occupying an SWCNT fragment 2.24 nm in
length, as determined by experiments. In the second set of simulations, the above system was
simulated for additional 327 ns. In these simulations, all the heavy atoms of (GT)15 were restrained
to occupy a 2.24 nm long fragment of SWCNTs, by means of a square potential
𝑉(𝑧) = 0; 𝑧 > −𝑧0 ∩ 𝑧 < 𝑧0
𝑉(𝑧) = 𝑉0 ; 𝑧 < −𝑧0 ∩ 𝑧 > 𝑧0
where 𝑉0 was gradually increased from 0.01 kcal/mol per atom to 0.1 kcal/mol per atom. Overall,
the second system was progressively simulated for 100 ns (𝑉0 = 0.01 kcal/mol, 𝑧0 = 1.1 nm), 100
ns (𝑉0 = 0.02 kcal/mol, 𝑧0 = 1.1 nm), 100 ns (𝑉0 = 0.03 kcal/mol, 𝑧0 = 1.1 nm), 100 ns (𝑉0 = 0.04
kcal/mol, 𝑧0 = 1.1 nm), and 200 ns (𝑉0 = 0.1 kcal/mol, 𝑧0 = 1.12 nm).
5.2.2 Data analysis
To analyze the stacking of (GT)15 on SWCNT surface in two simulations above, the contact area
between ssDNA and SWCNTs was calculated in time t, defined as
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a𝐷𝑁𝐴 (t) + a𝑆𝑊𝐶𝑁𝑇 (t) − a𝐷𝑁𝐴 ⋃ 𝑆𝑊𝐶𝑁𝑇 (𝑡)
2
where a𝐷𝑁𝐴 (t), a𝑆𝑊𝐶𝑁𝑇 (t), and a𝐷𝑁𝐴 ⋃ 𝑆𝑊𝐶𝑁𝑇 (𝑡) are the solvent-accessible surface areas of the
ssDNA, SWCNTs, and the ssDNA/SWCNT conjugate, respectively, at time t. The analyses were
performed during the last 50 ns of production runs. The contact area evaluation was performed by
the SASA built-in VMD plugin,25 where the van der Waals radius of 1.4 Å was assigned to atoms
to identify the points on a sphere that are accessible to the solvent.
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5.3 RESULTS

Figure 10. Molecular dynamics simulations of (GT)15 ssDNA on a (6,5)-SWCNT with
experimentally determined adsorption numbers as parameters. (a) Representative view of a
(GT)15–ssDNA molecule adsorbed on a (6,5)-SWCNT. ssDNA is restrained to stack on an
SWCNT segment of the length determined in experiments. When (GT)15 occupies the SWCNT
segment as determined in experiments, only a fraction of bases stack on the SWCNT, while the
rest of the bases stack on top of each other (less than half). (b) Representative view of a
(GT)15 molecule that fully adsorbs on a (6,5)-SWCNT. (c) Contact area between (GT)15 and
(6,5)-SWCNTs for systems shown in panels (a,b). In panels (a,b), the SWCNT is shown as a
white surface, and ssDNA atoms are shown in subdued blue (C), red (O), orange (P), and blue
(N) colors. Hydrogen atoms are not shown for clarity.
The experimentalist determined that on average one (GT)15 molecule occupies 2.2 nm long
segment of (6,5) SWCNT. To determine the most likely conformations of ssDNA molecules on
SWCNTs at such number densities, we performed above-described atomistic MD simulations of
(GT)15 molecules adsorbing on (6,5)-SWCNTs. (GT)15 molecules were adsorbed and simulated on
the SWCNT surface, either with restraints imposed, so that (GT)15 molecule spans the
experimentally determined segment length of SWCNTs, or without any restraints present. In both
simulations, ssDNA molecules initially wrapped SWCNTs in helical conformations.120 121 In a 100
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ns simulation of the (GT)15/SWCNT conjugate without any restraints present, ssDNA remained
helically wrapped and the majority of the bases stacked on the SWCNT, as shown in Figure 7b.
However, in a ∼500 ns simulation of the (GT)15/SWCNT conjugate, where (GT)15 was restrained
to occupy a 2.24 nm long segment of SWCNTs, only a fraction of bases can stack on the SWCNT,
while the rest of the bases stack on top of each other (Figure 7a). The analysis of the
(GT)15/SWCNT contact area, shown in Figure 7c, indicates that less than half of ssDNA bases
stack directly on the SWCNT surface in the system as shown in Figure 7a. Furthermore, the
thickness of the ssDNA corona around the SWCNT increased indicating that CNT surface is less
accessible at experimentally determined number densities than the (GT)15 bases stacked directly
on CNT. This shows that the experimentally determined number of bound ssDNA molecules is
important to understand the organic phase around SWCNTs and that this parameter affects MD
simulations significantly.
5.4 CONCLUSION
Our work shows that the mean available space for ssDNA on SWCNT should be
considered as an important factor of the molecular understanding of the events on the SWCNT
surface. Our results suggest that interactions between the ssDNA molecule itself play a more
important role than previously thought. In the future, MD simulations could use our experimentally
determined numbers as starting parameters. We have quantified and reported the numbers for
ssDNA bases forming a corona on SWCNT. Such parameters will be helpful to assess further
surface modification and can serve as parameters for MD simulations.
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Chapter 6: Computational modeling of broad-spectrum non-toxic antiviral nanoparticles
with a virucidal inhibition mechanism
6.1 INTRODUCTION
Among all the various infectious disease threats humans face from microorganisms, viral
infections are arguably the biggest pandemic threat in the modern. Viruses have high replication
rates, high rate of mutations and transmissibility.122 Even in absence of a pandemic, viral infections
kill millions of people every year. Available antiviral drugs are highly targeted against a specific
virus or, in some cases, members of a viral family. Current antiviral drugs include small molecules,
such as nucleoside analogues and peptidomimetics, monoclonal antibodies, proteins that are able
to stimulate the immune response, such as interferon, and oligonucleotides.123 These drugs act
intracellularly to allow for selectivity for viral enzymes but as viruses mostly depend for their
replication on infected host cells, the specificity of antiviral drugs for viral proteins is not ideal,
often causing general intrinsic toxicity upon administration.124
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Furthermore, due to high

mutation rates, most viruses develop drug resistance.126 Due to the use of virus-specific proteins
as targets of antiviral drugs, it is difficult to develop broad-spectrum therapeutics capable of acting
against a large number of viruses that are phylogenetically unrelated and structurally different.
Thus, there is a critical need to develop a broad-spectrum and non-toxic antiviral therapeutics.
One approach is to utilize substances known to interact with viruses outside of host cells,
where they interfere with the first phases of the viral replication cycle but many potential
substances, which can be broad-spectrum and non-toxic, exhibit only virustatic properties.127
Virustatic molecules, such as heparin and polyanions, can interact with a broad spectrum of viruses
because they target virus-cell interactions that are common to many viruses.128 129 130 131 132 Activity
of virustatic materials depends on a reversible binding event, which makes them therapeutically
ineffective: upon dilution, these materials detach from intact viral particles allowing the viruses to
infect again.
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Virucidal materials are more promising for use as drugs against viral infections. Virucidal
molecules cause irreversible viral deactivation, since their effect is retained even if their dilution
occurs after the initial interaction with the virus.133 Virucidal materials include simple detergents,
strong acids, polymers134, and nanoparticles135 136 137 138. All these materials have intrinsic cellular
toxicity since they attempt to chemically damage the virus and they cannot selectively damage the
virus without affecting the host in which the virus replicates.
One way to achieve a broad-spectrum efficacy can be development of novel therapeutic
materials that can target specific virus-cell interactions that are common to many viruses. One of
these interactions is between a viral attachment ligand and an associated cell receptor called
heparan sulfate proteoglycans (HSPG) which are responsible for the initial steps of the virus
replication cycle.127 Many viruses, including human papillomavirus type 16 (HPV-16), human
immunodeficiency virus 1 (HIV-1), herpex simplex virus 1 and 2 (HSV-1 and HSV-2), attach to
HSPGs, which are expressed on the surfaces of almost all eukaryotic cell types. It has been shown
that nanoparticles (NPs) with long and flexible ligands mimicking HSPG effectively associate with
such viruses and eventually lead to irreversible viral deformation. These non-toxic nanoparticles
(NPs) show in vitro irreversible virucidal activity against HSV-2, HPV-16, RSV, Dengue and
lentivirus. They are active ex vivo in human cervicovaginal histocultures infected by HSV-2 and
in vivo in mice infected with RSV as well.127
Here, we studied molecular interactions between gold nanoparticle with core diameter of
2.4 nm decorated with ligands mimicking HSPGs with capsid segments of two, three and four
HPV16 major late (L1) pentamer proteins using nanosecond scale atomistic molecular dynamics
(MD) simulations. Although over the simulation timescales, internal pentamer stability is not
compromised in the presence of NP, we identify the interface of two pentamers as preferred site
of interaction with NPs. Interaction at this site is facilitated by two solvent exposed loop regions one consisting of mostly polar or charged amino acids allowing long rang electrostatic interaction
with sulphate groups present on NPs and other consisting of mostly non-polar amino acids
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interaction with alkyl groups present on NP surface. Such interactions cause observable
perturbation in capsid segments and can lead to irreversible viral deformation.
6.2 METHODS
6.2.1 Constructing HPV capsid segments
Three capsid segments were constructed, having either two, three or four pentamers. The
arrangement of pentamers in these capsid segments was based on the Human Papillomavirus Type
16 capsid structure resolved by cryo-electron microscopy (PDB:3J6R)139. Disulfide bonds were
built between residue 161 and residue 324 for all segments, based on visual inspection.
For each pentamer in all the three systems, crystal structure of HPV16 L1 pentamer
(PDB:5W1O)140 was fitted in place of the relaxed pentamers using molecular dynamics flexible
fitting (MDFF) method.64 In MDFF simulations, L1 pentamer was coupled to the density obtained
from relaxed pentamers. For all the three systems, L1 pentamer was first docked with the relaxed
pentamer potential using colores (Situs) software with a resolution of 5 Å
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. Next, MDFF

simulations were performed in vacuum with scaling factor for potential (gscale (ξ)) set to 0.3. The
secondary structure along with cispeptide bonds and chirality of L1 pentamer were restrained
during the simulations.
The crystal structure of L1 pentamer was missing one loop region as well as some residues
at both C and N terminal of all segments of the pentamer. The missing residues were built in VMD
and covalently added at ends manually to the final obtained pentamer structure from the MDFF
simulations.
The prepared system was solvated with TIP3P water34 and neutralized with 0.15 M NaCl
with solvate and ionize VMD plugins, respectively.65
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6.2.2 Ligand Docking on HPV Pentamer
Sulphonated ligands (CH3CH2SO3-) were docked on the HPV pentamer using the
Autodock Vina software.141

Docking was performed using the crystal structure of the L1

pentamer, using the structural models of the ligand constructed in AMPAC GUI. This part of the
model building was performed by Payam Kelich. In Autodock Vina, the grid box was centered at
various positions on a grid, scanning the pentamer surface with five fixed Z-coordinates and
changing the X and Y coordinates from -40 Å to 40 Å for both with an interval of 1 nm, which the
Linux shell scripting automized the procedure. The coordinates with the highest affinity were taken
as the initial conformation for the MD simulation. Each grid box dimension was 1 nm3 × 1 nm3 ×
1 nm3 with a default spacing and exhaustiveness of 0.0375 nm and 8, respectively.
6.2.3 Nanoparticle Model
The model of the nanoparticle was prepared by Tara A. Nitka. Atomistic models of
spherical nanoparticles were prepared by cutting a face centered cubic lattice of gold (Au) atoms
(Au-Au bond length 2.88 Å) into spheres with diameter 2.4 nm and ligated with a random spherical
array of 1-octanethiol (OT) and 11-mercapto-1-undecanesulfonate ligands (MUS) in 1:1 ratio
forming MUS:OT-NP. All ligands were built in the AMPAC GUI and arranged into a random
spherical array with 0.3949 per Au atom surface density using our own code. These MUS:OT NPs
were then solvated with TIP3P water and ionized with sodium (Na+) and chloride (Cl-) ions at a
0.15 M NaCl concentration using the VMD solvate and ionize plugins.65 After solvation and
ionization, MUS:OT NPs were minimized for 2,000 steps using NAMD2.13 software25 and
equilibrated for 20 ns in the NPT ensemble with Langevin dynamics (Langevin constant γLang =
1.0 ps–1), where temperature and pressure remained constant at 310 K and 1 bar, respectively. The
particle-mesh Ewald (PME) method33 was used to calculate the Coulomb interaction energies, with
periodic boundary conditions applied in all directions. Long range van der Waals and Coulombic

47

interactions was performed every 1- and 2-time steps, respectively. A 2 fs time step was used for
equilibration of MUS:OT NPs.
6.2.4 Molecular Dynamics Simulations
Atomistic simulations were conducted to investigate interaction of nanoparticle and HPV
capsid segments. All the systems were described with CHARMM366 force field parameters. MD
simulations were performed with the NAMD2.13 package. All simulations were conducted with
Langevin dynamics (Langevin constant γLang = 1.0 ps–1) in the NPT ensemble, where temperature
and pressure remained constant at 310 K and 1 bar, respectively. The particle-mesh Ewald (PME)
method was used to calculate the Coulomb interaction energies, with periodic boundary conditions
applied in all directions. The evaluation of long-range van der Waals and Coulombic interactions
was performed every 1- and 2-time steps, respectively.
After 10,000 steps of minimization with timestep set to 2.0 fs, the 6 pentamer system was
progressively relaxed, first, for 0.61 ns with the protein backbone restrained by using harmonic
forces with a spring constant of 1 kcal/(mol Å2) and timestep set to 1.0 fs. Next, the system was
further relaxed for 3.075 ns with the protein backbone restrained by using harmonic forces with a
smaller spring constant of 0.1 kcal/(mol Å2) and timestep was increased to 1.5 fs. Next, the system
was further relaxed for 0.975 ns with the backbone of the secondary structure of the protein
restrained by using harmonic forces with a smaller spring constant of 0.1 kcal/(mol Å2) and
timestep was increased to 1.5 fs. Lastly, the system was relaxed in solvent without any restrains
applied for 3.9 ns with timestep set to 1.5 fs.
In total, six systems were prepared for final MD simulation runs. They consisted of two,
three and four pentamers with and without single MUS:OT NP. The systems with MUS:OT NP
were prepared by placing a single MUS:OT NP 10 Å above the interface of three pentamers (two
in case of two pentamer system) based on docking results. For all systems, 10,000 steps of
minimization were performed and after that solvent molecules were equilibrated for 2 ns around
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the pentamers, which were restrained by using harmonic forces with a spring constant of 1
kcal/(mol Å2). Next, the systems were equilibrated in production MD runs, with center-of-mass
(COM) restraints applied to α-carbon of a buried residue (chosen to be residue 331) for all
segments of the pentamers with a force constant of 2.0 kcal/mol, so the molecule remains in the
original unit cell. The atoms within 5 Å of the XY plane containing the origin of the solvent box
were constrained along z-axis with a square walled potential centered at the origin with width of
10 Å and wall potential of 100.0 kcal/mol, so that the pentamer system does not tilt on whole
leading to interaction with neighboring unit cell. The length of production MD runs were 200 ns
for two and three pentamer systems and 115 ns for 4 pentamer system.
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6.3 RESULTS
6.3.1 Effect of nanoparticle on dynamics of capsid segments

Figure 11. Conformations of different capsid segments drawn as ribbon, in presence and absence
of MUS:OT nanoparticle drawn as surf at initial and final time. a) Two pentamer system
consisting of pentamer A (blue) and pentamer F (red) without MUS:OT NP at initial time (left)
and final time (right). b) Side view (top) and top view (bottom) of two pentamer system with
MUS:OT NP. MUS ligand is colored in purple while OT ligand is teal colored. c) Final
conformations (at 200 ns) of three pentamer system consisting of pentamer A, F and B (green)
with (bottom) and without (top) MUS:OT NP. d) Final conformations (at 115 ns) of four
pentamer system consisting of pentamers A, F, B and C (yellow ochre) with (bottom) and
without (top) MUS:OT NP.
As shown in Figure 11, the MUS:OT NP interacts strongly and form stable interactions with HPV
16 L1 capsid protein pentamers. However, the MUS:OT NP is unable to distort individual LI
pentamers structurally within the simulated time. Based on MD simulations and docking results,
the MUS:OT NP prefers to interact with only at the junction of two L1 pentamers as shown in
Figure 11. In case of three and four pentamer systems, we initially placed MUS:OT NP was above
junction of three L1 pentamers - A, B and F. Over the course of simulation, we observe that in
both cases, the MUS:OT NP shifts from three pentamer junction to two pentamer junction. Figure
11c shows that in case of three pentamer system the MUS:OT NP shifts and preferably bind to A50

F pentamer junction whereas Figure 11d shows that MUS:OT NP shifts to B-F pentamer junction
in four pentamer system. The shift of MUS:OT NP to two pentamer junction happens at around
30 ns for three pentamer system and around 70 ns for four pentamer system indicating the strong
preference MUS:OT NP with core diameter of 2.4 nm, to interact with two pentamer junction.
Such preference indicates that a single L1 pentamer can effectively interact with only five
MUS:OT NPs at a due to the geometry of the capsid segment. MUS type NPs with larger size
may be able to interact with three pentamer junctions effectively and can lead to increased
distortion of capsid segment.
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Figure 12. a) Distance between the center of mass of two pentamers calculated over 200 ns long
simulation for two pentamer system. b) Angle between the planes containing respective
pentamers for 200 ns long simulation of two pentamer system.
In order to measure capsid segment distortion in presence of MUS:OT NP, we calculated distance
between center of mass (COM) of two adjacent pentamers and angle between the planes containing
L1 opening for two adjacent pentamers. Figure 12 shows that in two pentamer system, the
MUS:OT NP is able to “wedge in” to a certain extend between the two pentamers distorting the
capsid segment as shown in Figure 11a, right. Both the distance between the interacting pentamers
and angle between the planes of pentamers increases in presence of NP indicating that MUS:OT
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NP can change orientation of pentamers with respect to each other and perturb the capsid segment.
At two pentamer junction, MUS:OT NP can force pentamers to be further apart and more tilted
with respect to each other as compared with the control.

Figure 13. a) Distance between the center of mass of two pentamers A and F that participate in
interaction with MUS:OT NP calculated over 200 ns long simulation for three pentamer system.
b-c) Distance between the center of mass of two pentamers pairs (A-F and B-F) that participate
in interaction with MUS:OT NP calculated over 115 ns long simulation for four pentamer
system. d) Angle between the planes containing respective pentamers mentioned in (a) calculated
over 200 ns long simulation of three pentamer system. e-f) Angle between the planes containing
respective pentamers mentioned in (b-c) calculated over 115 ns long simulation of three
pentamer system.
Similar observations are made for three pentamer and four pentamer systems as well. Figure 13a,d
shows that both the distance and angle between pentamers A and F increases in presence of
MUS:OT NP in three pentamer system. Note that pentamer C does not interact with MUS:OT NP
in this system, and hence is not included in analysis. This “wedge in” effect starts after 100 ns in
two pentamer system and after 60 ns in three pentamer system (Figure 12, 13a,d). In case of four
pentamer system, the pentamer moves from A-F-B pentamer junction to A-B pentamer junction
(Figure 11d). Analysis of distance and angle between pentamers involved in A-F and A-B junction
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which are affected in presence of MUS:OT NP; show much less pronounced effect on capsid
segment as compared with smaller systems, as shown in Figure 13b,c,e,f. This indicates that stable
interaction with two pentamer junction is essential for capsid segment distortion as seen in two
and three pentamer systems whereas in case of four pentamer system, the MUS:OT NP seems to
scan for preferred binding site (B-F pentamer junction) within the simulation time which does not
allow it to effectively interact with any two pentamer junction to cause disruption of capsid
segment within 115 ns. We believe that with longer simulation time MD runs, should be able to
effectively capture capsid segment disruption caused by MUS type NPs in larger systems
consisting of many L1 pentamers. In all cases we observe that in presence of MUS:OT NP, the
distance between center of mass (COM) of two adjacent pentamers can vary from 1 Å to 5 Å as
compared with control and the angle between two pentamers vary from 2 to 8 degrees as compared
to the control.

54

6.3.1 Interaction of nanoparticle with capsid protein

Figure 14. a) Typical interaction of MUS:OT NP with L1 pentamer protein (blue and red). The
MUS:OT NP “wedges in” between two pentamers and interact with upto four exposed surfaces
of four different protein segments of the pentamers denoted by seg A5 (yellow ochre), seg F2
(black), seg F1 (pink) and seg A1 (green). b) RMSD values of secondary structure calculated for
these protein segments. c) Structure of a typical segment shown in red. Five such segments form
one L1 pentamer capsid (blue). The green spheres denote the α-carbon of residues that interact
with MUS:OT NP. The segment has two solvent exposed surface planes S1 and S2. The scale
bar is 10 Å (black).
MUS:OT NP interacts with mostly flexible loop regions that are protruding from the capsid
surface into the solvent at two pentamer junction as shown in Figure 14a,c These loop regions are
also known to interact with heparin oligosaccharides140 indicating that MUS:OT type NPs can
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mimic HSPG cell receptors allowing for effective viral association.126 Each pentamer consists of
five structurally similar segments. A two pentamer junction consist of interaction of four such
segments from two different pentamers (two segments from each) as shown in Figure 14a. In case
of two pentamer system, the MUS:OT NP is able to “wedge in” between the center of these four
segments (segments A1, A5, F1 and F2) as shown in Figure 14a. Similar interaction dynamics
were observed in case on three pentamer system (MUS:OT NP interacts with A-F junction
consisting of segments A1, A5, F1 and F2) and four pentamer system (MUS:OT NP interacts with
B-F junction consisting of segments B1, B2, F1 and F2) as well. The secondary structure of
individual segment is preserved during the interaction with MUS:OT NP as shown in Figure 14b.
Overall, the MUS:OT NP interaction with capsid proteins does not affect secondary structure of
individual segments and pentamers within the simulation time but does affect the capsid segment.
We can consider L1 pentamer shaped as a cylindrical object with 5 arms protruding in
space belonging to five structurally similar segments. Due the presence of this arm, each segment
can be considered as regular tetrahedron shaped with two surfaces exposed to solvent, one buried
and protruding arm at one of the vertex as shown in Figure 14c,d. The MUS:OT NP can only
interact with maximum four such surfaces at a time belonging to four different segments (two of
each belonging to different pentamers) of two different segments of two pentamers and as the
pentamers begin to tilt with respect to each other the MUS:OT NP interacts with any one pentamer
more strongly than other due to size limitation. We believe, as observed in previous subsection,
that larger sized NP will be able to disrupt capsid segment more effectively.
Figure 14c show the position of residues that interact with MUS:OT NP. As each segment
is structurally similar, the MUS:OT NP interact with the two unique surfaces of the segment named
S1 and S2 as shown in Figure 14c. For the S1 surface, the MUS:OT NP interacts with three loop
regions (residue id 52-62, 345-362 and 424-432) denoted by S1:52-62, S1:345-362 and S1:424432 respectively, and for surface S2, the MUS:OT NP interact with two loop regions (residue id
172-186 and 265-286) denoted by S2:172-186 and S2:265-286 respectively. These loop regions
are a mix of charged and non-polar amino acids which correlates well with previous MD study of
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single L1 pentamer with MUS:OT NP127 which demonstrated interaction between the negative
sulfonate groups of MUS:OT-NP and the positive HSPG-binding lysine residues of loop regions
and interaction between non-polar alkyl chains of NP ligands and L1 proteins.

Figure 15. a) Typical interaction of NP with L1 pentamer junction for two and three pentamer
system (top) and for four pentamer system (bottom). Interacting segments are highlighted in
different colors. Contact map of amino acid residues present in interacting loop regions of
different protein segments of L1 pentamer capsid protein with MUS:OT NP calculated over 115
ns long simulations for b) four pentamer system and for 200 ns long simulation of c) two
pentamer system and d) three pentamer system. A contact is defined as any part of the residue
within 5 Å of MUS:OT NP.
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Figure 15 shows that interaction of MUS:OT NP with two pentamer junction is biased towards
one pentamer than the other - pentamer A in both two and three pentamer systems and pentamer
F in four pentamer system. We observe that MUS:OT NP interact with loop regions of all four
surfaces (S1 and S2 of both pentamers) in two and three pentamer system but interact with only
three surface regions in larger system. This is due the fact that interplay of dynamics between
pentamers force these surface regions to be further apart from each other as compared to two
pentamer system which only allows MUS:OT NP to interact with upto three surface
regions.(Figure 15).
S1 surface interaction with MUS:OT NP is significantly larger as compared to with S2
surface. This is due to the significant interaction with S1:52-62 loop region (Figure 15) which
contain positively charged Lysine (residue id: 53,54 and 59) and polar Asparagine (residue id: 5658) which interact strongly with the negative sulfonate groups of MUS:OT-NP. Interaction with
S1:52-62 is significant in all three systems indicating the importance of this region in establishing
initial binding of L1 pentamer with MUS:OT NP through long range electrostatic interactions.
In case of S2 surface, the loop region S2:172-186 interacts more strongly as compared to
other regions as shown in Figure 15 due to interaction between non-polar residues and alkyl chains
of NP ligands. Figure 15c shows MUS:OT NP starts binding to B-F pentamer at around 70 ns with
biased binding to F pentamer. S1:52-62 loop regions on segments B1 and F2 play significant role
in binding followed by S2:172-186 loop region of segment F1. These two loop regions which face
each other at two pentamer junction seem to play key role in binding of MUS type NPs to capsid
proteins allowing “wedge in” effect which should disrupt the capsid segment.
6.1 CONCLUSION
In this work, we have modelled the interactions between nanomaterials coated with ligands
mimicking HSPGs and HPV-16 proteins that recognize host cell HSPGs using classical atomistic
molecular dynamics (MD) simulations. We determined initial molecular mechanisms responsible
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for the virucidal activity of these nanomaterials and identify the key regions on viral capsid surface
that facilitate such interactions. Such knowledge can be utilized for designing new generations of
related optimized virucidal materials and contribute to the development of new broad-spectrum
and non-toxic virucidal materials.
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Chapter 7: Modeling structure of APOBEC3G protein and its interactions with ssDNA
molecules
7.1 INTRODUCTION
APOBEC ("apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like") proteins
belong to a family of evolutionarily conserved cytidine deaminases. They have diverse and
important functions in human health and disease.142 Out of 11 members of the family,
APOBEC3G (A3G) has been shown to have the highest anti-viral activity against HIV-1 virus.
A3G restricts the replication of HIV-1, hepatitis B virus, retrotransposons, and other DNA-based
parasites.143 In infected cells, A3G inhibits viral replication through the specific deamination of
Cytosines (C) in viral minus-strand DNA resulting in huge G to A hypermutation of the viral DNA
genome during reverse transcription.144 145
A3G has a conserved zinc-dependent deaminase sequence motif (ZDD) within a α-β-α
super secondary structural element that forms the catalytic site of a C-terminal domain (CTD)
domain as shown in Figure 16.146

147 142

A3G deaminates two consecutive cytidines (bold) in a

strict 3ʹ to 5ʹ order in 5ʹ-CCCA-3ʹ motif in ssDNA.148 Of the two homologous domains, the
catalytically inactive N‐terminal domain (NTD) required for Vif, DNA and RNA binding and is
positively charged, and the catalytically active C‐terminal domain (CTD) required for catalysis
and base sequence specificity.149
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Figure 16. Schematic representation of ZDD domain with beta sheets represented by arrows
while cylinder denotes the alpha helix. H, C and E denote amino acids histidine, cysteine and
glutamic acid respectively.
High-resolution atomic structure of a full-length functional human A3G remains
undetermined, due to oligomerization and precipitation of A3G at concentrations required for
crystallization.150 Expression and purification in bulk has also been very difficult using bacterial
expression systems as these proteins are genotoxic and are frequently insoluble as full-length
proteins.151 152 However, structures of individual mutated CTD and NTD have been determined by
NMR spectroscopy and X-ray crystallography153 154, and the shape of the full-length A3G protein
was revealed by small-angle X-ray experiments and advanced envelope restoration methods.155 156
Previous work done by our lab in collaboration with Prof. Yuri Lyubchenko (U. Nebraska)
resulted in the atomic scale model of the full-size A3G via computational modeling and docking
of A3G C-terminal and N-terminal domains based on available structures of CTD and NTD of
A3G, followed by microsecond-long molecular dynamics (MD) simulations.157 These simulations
revealed a highly dynamic feature of A3G monomer that can lead to extended conformations in
which two domains are separated by distances as large as 4.5 nm.
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According to recent AFM studies158, such dynamical conformation change should allow
A3G to assume dumbbell conformation of A3G may allow CTD domain to efficiently search for
the deamination spot on ssDNA substrate, while NTD domain remains strongly attached to the
ssDNA substrate. A3G is known to scan for preferred motif (5ʹ-CCC-3ʹ) for deamination by
different mechanisms that are categized as sliding, jumping and intersegmental transfer.159 160 The
dumbbell conformation should allow enzyme to be more flexible and positively charged NTD
domain to effectively interact with negatively charge backbone of ssDNA without the interference
of overall negatively charge CTD domain.
Current computational model, however, is not ideal to study such dynamics of
protein:ssDNA complex as initial ensemble of A3G structures has predominantly globular
conformations because the docking procedure favors structures where CTD and NTD interact with
each other, rather than being fully immersed in the solvent. Both A3G and A3G: ssDNA complex
behavior in solution during MD simulations does not correlate with experimentally determined
properties: A3G remains in globular conformation on microsecond timescale. Computational cost
of running atomistic MD simulations on longer time scales is very high, hence impractical. Thus,
our goal is to develop a better computational model of A3G which is more dynamic and correlates
with experimental data.
In this chapter, I describe how we improve upon previous computational model using
structural information from recently solved crystal structure of Rhesus Macaque full length
A3G161, and utilized coarse grained MD simulations to access longer timescales and understand
interaction of A3G with ssDNA.
7.2 METHODS
7.2.1 All atomistic (AA) models
Due to lack of structural data of full length human, we chose computational model of full
length A3G based on previous work involving MD simulations of docked ensembles CTD and
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NTD as our starting model.157 This docked model consisted of C-terminal domain with the linker
(PDB:2KBO, residues 196-384)162 and N-terminal domain (PDB:5K83, residues 1-195).163 The
CTD structure had a wild-type sequence and NTD crystal structure contained 57 mutations from
the wild-type sequence (UniProtKB code: Q9HC16)164 which were mutated back to their
corresponding wild-type residues within VMD.65 A missing loop (residues 139–142) on NTD was
added with VMD, by alignment to another solved NTD structure (PDB:2MZZ)154. The NTD was
relaxed and simulated for 100 ns prior to docking. Zn2+ ions were placed into the active site pockets
after docking.
In starting structure was further refined by structural alignment by full-length structure of
A3G (rA3G) found in rhesus macaque (PDB: 6P3X).161 For this, the starting structure was divided
into two parts, one part containing residues 1 to 207 and other part containing residues 208 to 384.
These two parts were structurally aligned into their corresponding domains present in rA3G and
then combined to build the initial A3G structure.
The initial structure was solvated with TIP3P water34 and neutralized with 0.15 M NaCl.
After 2,000 steps of minimization, the solvent molecules were equilibrated for 1 ns around the
initial structure, which were restrained by using harmonic forces with a spring constant of 1
kcal/(mol Å2). After that the linker region (residues 196-218) was relaxed with the rest of the
protein restrained by using harmonic forces with a spring constant of 1 kcal/(mol Å2). The relaxed
structure was then simulated for 100 ns in three different trials with different seed value, with
center-of-mass (COM) restraints applied to three random buried residues of CTD with a force
constant of 1.0 kcal/mol, so the molecule remains in the original unit cell. NTD was unrestrained.
The final structures obtained from the three trials were used to build initial structures of
A3G-ssDNA complexes by placing ssDNA adjacent to A3G model guided by the alignment of
available crystal structures of individual domains in complexes with ssDNA. These structures
include CTD with 9 nucleotide long ssDNA (PDB: 6BUX)165 and NTD with 9 nucleotide long
ssDNA (PDB: 5K83)163. In total, six systems were prepared ; three systems with ssDNA bound to
CTD and three systems with ssDNA bound to NTD. All the six prepared systems were solvated
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with TIP3P water and neutralized with 0.15 M NaCl with solvate and ionize VMD plugins,
respectively.65
7.2.2 AA Molecular Dynamics simulations
Atomistic simulations were performed to investigate dynamics of A3G protein complexes
with ssDNA. All the systems were described with CHARMM36 force field parameters.6 MD
simulations were performed with the NAMD v2.13 package.25 All simulations were conducted
with Langevin dynamics (Langevin constant γLang = 1.0 ps–1) in the NPT ensemble, where
temperature and pressure remained constant at 310 K and 1 bar, respectively. The particle-mesh
Ewald (PME) method33 was used to calculate the Coulomb interaction energies, with periodic
boundary conditions applied in all directions. The evaluation of long-range van der Waals and
Coulombic interactions was performed every 1- and 2-time steps, respectively.
All six systems were relaxed for 10,000 steps after which the solvent molecules were
equilibrated for 1 ns around the initial structure, which were restrained by using harmonic forces
with a spring constant of 1 kcal/(mol Å2). After that the ssDNA was relaxed with the protein
restrained by using harmonic forces with a spring constant of 1 kcal/(mol Å2). The relaxed structure
was then simulated for 100 ns, with center-of-mass (COM) restraints applied to three random
buried residues of CTD with a force constant of 1.0 kcal/mol, so the molecule remains in the
original unit cell. NTD was unrestrained.
7.2.1 Coarse grained (CG) models and MD simulations
CG models were built for atomistic structures described above, obtained after 100 ns AA
simulations. These structures include three trials each of A3G, A3G with ssDNA bound to CTD
and A3G with ssDNA bound to NTD. CG models were built using python scripts available on
MARTINI website.166

31

All nine systems were solvated with standard MARTINI water model

having 10 % anti-freeze water and neutralized with 0.15 M NaCl using program package
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GROMACS (version 2019.x).167 Zinc ions were removed from the final structure and secondary
structure of A3G was distance restrained by harmonic potentials between atoms with a distance
cutoff of 1.5 nm. All simulations were performed with GROMACS (version 2019.x) using the
Martini force field v2.1 in NPT ensemble with temperature and pressure set to 310 K and 1 bar,
respectively. The time step is set to 30 fs for protein systems and 20 fs for protein:ssDNA complex.
All simulations were performed using velocity rescale thermostat168, Berendsen (for minimization)
and Parrinello–Rahman barostat.169 After 50,000 steps of minimization, the solvent was
equilibrated for 5 ns with time step of 1 fs. All systems were then equilibrated in production MD
runs of 10 µs with distance restraints applied as aforementioned.
7.3 RESULTS
7.2.2 Dynamics of A3G monomer

Figure 17. a) Initial structure of the A3G consisting of two domains CTD (red), and NTD (blue),
linked by a flexible loop region (green). Zn2+ ions are shown as cyan spheres b) Histograms of
distance d between center of mass of CTD and NTD for three 100 ns long AA simulations. c)
Time evolution of same. d-f) Contact maps between CTD and NTD at 100 ns for different trials.
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The conformational space of A3G is likely highly rugged and depend on domain-domain
interactions. Figure 17b-c shows that three 100 ns AA simulations lead to different final
conformations of A3G domains based on distances between the center of mass(COM) of CTD and
NTD. Trial 1 shows that CTD and NTD domains are able to break domain-domain interactions
(Figure 17d) and attain a dumbbell conformation with distance between COM of two domains
reaching around 42 Å at the end of the simulations. Trial 3 shows that new domain-domain
interactions can be formed (Figure 17f) and the distance between the COM of two domains is
reduced to 35 Å leading to a highly globular conformation. Trial 3, on the other hand, is stuck in
a globular conformation (Figure 17b) for the entire length of the simulation with unchanging
domain-domain interactions (Figure 17e).

Figure 18. Distance between the center of mass of CTD and NTD calculated over 10 µs long CG
simulations (left) and histogram of the same (right).
In 10 µs CG simulations of A3G starting from final conformations from AA simulations,
all the conformations return to globular shapes with mean distance between domain varying from
36 to 38 Å (Figure 18). The conformational space of globular A3G is highly dynamical, with A3G
domains readjusting with respect to each other.(Figure 18a). The globular shape seems to be
energetically favorable and indicates the presence of high energy barrier between globular and
dumbbell conformations.
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7.2.2 Interaction of ssDNA with A3G monomer

Figure 19. a) Time evolution of distance between center of mass of CTD and NTD for three
trials of 100 ns long AA simulations with ssDNA in complex with CTD. b) Histogram of the
same. c) Protein-DNA contact area for three trials of 100 ns long AA simulations with ssDNA in
complex with CTD. d) Histogram of the same. e) Same as (a) except the DNA is in complex with
NTD instead of CTD. f) Histogram of the same. g) Same as (c) except the DNA is in complex
with NTD instead of CTD. h) Histogram of the same.
In presence of DNA, there is minimal conformational change in A3G, as observed in
distances between the domains in 100 ns long AA simulations, shown in Figure 19a,e. Interaction
of ssDNA with A3G is highly dynamic. In case of ssDNA in complex with CTD (Figure 19c,d),
the ssDNA interacts with A3G more in trials 2 and 3, which are in globular conformations as
compared to trial 1, where A3G is in dumbbell conformation. This indicates that ssDNA has more
interaction with globular conformations which are thought to be essential for catalytic activity as
opposed to dumbbell conformations which allow CTD domain to reduce interaction with ssDNA
and scan for preferred motif in ssDNA at different site as proposed by recent AFM studies.158
Figure 19g,h shows that the interaction with NTD bound DNA does not seem to depend on the
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whole A3G conformation, which is correlated with previous experimental studies showing that
NTD is a non catalytic domain and binds non-specifically to ssDNA.163

Figure 20. a) Distance between the center of mass of CTD and NTD, calculated over 10 µs long
CG simulations with ssDNA in complex with CTD (left) and histogram of the same (right). b)
same as a except ssDNA in complex with NTD instead of CTD.
As shown in Figure 20a, A3G with ssDNA bound to CTD remains in globular
conformation at microsecond scales. Trial 1, which was initially in dumbbell shape transitions to
globular conformation as well. In Figure 18b, A3G conformations that have greater distance
between the domains (trial 1 and 2) are more dynamic and seem to switch between conformations
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which are globular and “dumbbell-like”. Overall, the average distance between the domains for all
three trials is the largest in the case of A3G in which ssDNA bound to NTD, followed by A3G in
which ssDNA is bound to CTD, and the smallest in A3G alone (Figure 19, 20). This supports the
experimental data which indicates that A3G population shift towards dumbbell conformation in
presence of ssDNA and even more if ssDNA is bound to NTD which allows CTD to scan for
preferred motifs in ssDNA for catalytic activity.
7.4 CONCLUSION
We demonstrated that CG simulations are faster and computationally efficient to
understand dynamics of A3G and its interaction with ssDNA. CG simulations allow access to
microsecond time scales for such systems to better sample the conformational energy landscape,
which is highly rugged in such systems. Our studies show that CG computational model of A3G
is able to capture some dynamics observed in experiments, but further studies are required and are
ongoing to understand mechanism of interaction of ssDNA with A3G.
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Chapter 8: Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2
8.1 INTRODUCTION
The very fast spreading of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the human population has already led to hundreds of thousands of fatalities and dire
socioeconomic effects worldwide. Therefore, many concepts and strategies were initiated to
identify drug targets170, develop effective therapeutics and vaccines against SARS-CoV-2 171 172,
including the optional use of therapeutics developed for other purposes.173
strategies have focused on direct targeting of the spike (S) protein175

174

Some of the

176

, located on the outer

surface of the SARS-CoV-2 virion, which initiates the cell entry process. This process starts by
binding of the receptor binding domain (RBD) on the S protein to a human host receptor
angiotensin converting enzyme 2 (ACE2), followed by a proteolytic cleavage and release of its S1
subunit.177 Then, the remaining S2 subunit undergoes a conformational change, which eventually
leads to virus–host membrane fusion.178 The S protein RBD of SARS-CoV-2 binds more strongly
to ACE2 than SARS-CoV.179 This fact, together with other innovative characteristics of the S
protein, including a furin preactivation of the cleavage site, and a hidden RBD, likely contributes
to the large infectivity of SARS-CoV-2.179
SARS-CoV-2 is mutating and further adjusting to the human environment, like other novel
viral pathogens. Many strains of SARS-CoV-2 have already been detected.180 Some mutations,
such as D614G on the S protein, lead to rapid and enhanced viral transmission 181, causing this
strain to locally dominate. The mutating SARS-CoV-2 coronavirus could also adapt to new hosts,
such as domestic animals.182 Therefore, to mitigate the large spreading and effects of SARS-CoV2, it is important to identify classes of therapeutics that could be rapidly developed to act against
multiple coronavirus strains.
In this chapter, I describe how we address this problem by introducing libraries of adaptive
peptide therapeutics that could block different S protein strains from interacting with ACE2. With
the use of advanced computational methods, we show that adaptive evolution of suitable peptide
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templates can provide multiple inhibitors for competitive binding to different S protein variants.
Using libraries of peptides adapted to different S protein variants could prevent their mutational
escape, in analogy to using cocktails of S protein antibodies.175 Our algorithm can evolve peptide
inhibitors that competitively bind to (block) a set of desired targets, such as different S protein
variants, S proteins with glycan shielded sites183 184, and other related systems.185
8.2 METHODS
8.2.1 Molecular Dynamics Simulations
The simulated peptides template-1 (amino acids 21–43 of ACE2) and template-2 (amino
acids 19–83 of ACE2) were separately bound to the S protein RBD. Template-1 size is typical of
peptides that can be chemically synthesized easily and quickly for experimental testing. Previous
simulations have demonstrated that the extracted ACE2-based helix of template-1 loses the
curvature and shape complementarity to the RBD binding site, a larger template-2 was also
selected for sequence optimization.176 Template-2 contains two helices that can preserve helix
curvature and shape complementarity to the RBD binding site. All structures were directly based
on the crystal structure of the human ACE2 protein bound to the SARS-CoV-2 Spike protein RBD
(pdbID: 6LZG).177 The mutations in peptides and RBD were introduced using the psfgen plugin
in VMD.65
The systems were simulated using NAMD2.1325 and the CHARMM36 protein force field.6
The simulations were conducted with the Langevin dynamics (𝛾Lang = 1 ps−1) in the NpT ensemble,
at a temperature of T = 310 K and a pressure of p = 1 bar. The particle-mesh Ewald (PME) method
was used to evaluate Coulomb coupling, with periodic boundary conditions applied.33 The time
step was set to 2 fs. The long-range van der Waals and Coulombic coupling were evaluated every
1- and 2-time steps, respectively. After 2000 steps of minimization, the solvent molecules were
equilibrated for 1 ns, while the complexes were restrained using harmonic forces with a spring
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constant of 1 kcal (mol Å)−1. Next, the systems were equilibrated in 100 ns production MD runs
with no restraints.
8.2.2 MMGB-SA Calculations
The molecular mechanics generalized Born–surface area (MMGB-SA)method186

187

was

used to estimate the relative binding free energies between peptides (or ACE2) and RBDs. The
free energies were estimated from separate MMGB-SA calculations for three systems
(peptide/ACE2, RBD, and the whole complex) in configurations extracted from the MD
trajectories of the whole complex in the explicit solvent. The MMGB-SA free energies of the
extracted configurations of the three systems were calculated as
𝐺𝑡𝑜𝑡 = 𝐸𝑀𝑀 + 𝐺𝑠𝑜𝑙𝑣−𝑝 + 𝐺𝑠𝑜𝑙𝑣−𝑛𝑝 − 𝑇𝛥𝑆𝑐𝑜𝑛𝑓
where 𝐸𝑀𝑀 , 𝐺𝑠𝑜𝑙𝑣−𝑝 , 𝐺𝑠𝑜𝑙𝑣−𝑛𝑝 , and 𝛥𝑆𝑐𝑜𝑛𝑓 are the sum of bonded and Lennard-Jones energy
terms, the polar contribution to the solvation energy, the nonpolar contribution, and the
conformational entropy, respectively. The 𝐸𝑀𝑀 , 𝐺𝑠𝑜𝑙𝑣−𝑝 , and 𝐺𝑠𝑜𝑙𝑣−𝑛𝑝 terms were calculated using
the NAMD 2.13 package25 generalized Born implicit solvent model188, with a dielectric constant
of the solvent of 78.5. The 𝐺𝑠𝑜𝑙𝑣−𝑛𝑝 term for each system configuration was calculated in NAMD
as a linear function of the solvent-accessible surface area (SASA), determined using a probe radius
of 1.4 Å, as 𝐺𝑠𝑜𝑙𝑣−𝑛𝑝 = 𝛾SASA, where 𝛾 = 0.00542 kcal mol−1 Å−2 is the surface tension. The
𝛥𝑆𝑐𝑜𝑛𝑓 term was neglected, since the entropic contribution differences nearly cancel when
considering protein–protein binding of single residue mutants.189 190 Moreover, the entropy term,
which is often calculated with a large computational cost and low prediction accuracy, is likely to
be similar for the studied systems, which differ in single or several mutations. Since the 𝐺𝑡𝑜𝑡 values
are obtained for peptide configurations extracted from the trajectories of complexes, 𝐺𝑡𝑜𝑡 does not
include the free energies of peptide reorganization; the correct free energies of binding should
consider configurations of separately relaxed systems. The approximate binding free energies of
the

studied

complexes

were

calculated

as
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⟨𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ⟩ = ⟨𝐺𝑡𝑜𝑡 (𝑃⁄𝐴𝐶𝐸2 − 𝑅𝐵𝐷 ) −

𝐺𝑡𝑜𝑡 (𝑃⁄𝐴𝐶𝐸2) − 𝐺𝑡𝑜𝑡 (𝑅𝐵𝐷)⟩ where P/ACE2 represents peptides or complete ACE2, and the ⟨
averaging ⟩ is performed over configurations within the second half of the calculated trajectories.
8.2.3 Adaptive Evolution Algorithm
A mutation/selection algorithm was developed and used to iteratively increase the affinity
of binding between peptide templates and the S protein RBD. The algorithm involved sequences
of steps combining molecular dynamics simulations and MC decisions using the Metropolis
criterion191 192, which resulted in MC sampling of the peptide sequence space. Initially, the selected
peptide template (directly extracted from ACE2) complexed with RBD was equilibrated for 100
𝑎𝑓𝑡𝑒𝑟

ns. Then, the free energy of binding of the peptide:RBD complex, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 was evaluated.
Next, a random mutation was introduced at a random position in the peptide, followed by a short
𝑎𝑓𝑡𝑒𝑟

1–10 ns equilibration in MD simulations of the complex, and evaluation of the 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 free
𝑎𝑓𝑡𝑒𝑟

𝑎𝑓𝑡𝑒𝑟

energy of binding of the complex. Finally, the mutation was accepted if 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 < 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴
or if the Metropolis criterion was satisfied,
𝑎𝑓𝑡𝑒𝑟

𝑏𝑒𝑓𝑜𝑟𝑒

𝑒𝑥𝑝[−(𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 − 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 )⁄𝑘𝐵𝑇] > 𝑟
where r is a random number in the (0,1) interval. If the mutation is accepted, then the new peptide
𝑏𝑒𝑓𝑜𝑟𝑒

becomes the new reference peptide and its 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 becomes the reference value 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴
for the next attempted mutation. In each run of the algorithm, 100–200 mutations were attempted
on peptide templates, as stated in the results.
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8.3 RESULTS
8.3.1 S protein variants

Figure 21. Mutations of SARS-CoV-2. a) Time-dependent mutation tree of SARS-CoV-2
colored according to geographical regions of origin (through June 2020).[21] b) Twenty-five
single mutations identified in RBD of the S protein. c) Five amino acid mutations on RBD in
contact with the ACE2 receptor. d) Binding free energies are evaluated with the MMGB-SA
method for the ACE2-RBD complexes, including the originally reported RBD (wild type,
labeled as WT) and the five mutant RBDs listed in panel (c).
Over the time and geographical regions, SARS-CoV-2 virus has so far evolved into more than 104
mutated strains, shown in the mutation tree of publicly available unique genome sequences
(through June 2020) in Figure 21a.193 Out of these mutations, so far (June 2020) 25 have been
recognized in the S protein RBD, as summarized in Figure 21b. Five of these mutations include
amino acids that form a part of the ACE2-binding surface (A475V, G476S, S477I, V483A, and
V503F), as highlighted in Figure 1c. The information above was identified by a collaborator
Yanxiao Han.
In Figure 21d, we present the RBD-ACE2 host-receptor binding free energies, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ,
obtained in the presence of these five mutations. The 5 RBD:ACE2 complexes are simulated for
30 ns, and their average binding energies are obtained in the last 15 ns. The originally reported
RBD and the S477I RBD have the strongest binding to the human ACE2, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 , ≈ −50 kcal
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mol−1, while the other systems bind with 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 , ≈ −(40–50) kcal mol−1. In order to block all
these RBD variants, the peptide inhibitors should have comparable or lower ΔGMMGB-SA
values.
8.3.2 Adaptation of Peptides by Single Mutations
Two ACE2-based peptide structures, shown in Figure 22a, are selected as templates for the
first generation peptide inhibitors of the S protein.176 The smaller template-1 includes single
truncated 𝛼1 helix of ACE2 (amino acids 21–43), and the larger template-2 includes two 𝛼1𝛼2
helices of ACE2 (amino acids 19–83). In the adaptive evolution search for optimized therapeutics,
the selected ACE2-extracted peptide templates will be gradually mutated to increase their binding
strength to RBD.
In recent mutagenesis experiments, the whole ACE2 with single mutations in regions
directly contacting RBD were examined for their binding to the original S protein.194 To perform
preliminary testing of our adaptive evolution search of peptide therapeutics, we first selected the
most fit mutants from these experiments and implemented their mutations in our templates- 1,2.We
simulated 22 peptides, that is, the original templates and their 10 single mutants, complexed with
the original S protein RBD. Their free energies of binding, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 , were evaluated in 100 ns
simulations and presented in Figure 22b. Template-1 binds to RBD with 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −19 kcal
mol−1, while its mutants have higher affinities giving 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −(24–35) kcal mol−1. In all
cases, template-1 significantly changes its conformation in the bound configuration, as the helix
loses the curvature observed when within ACE2, and the hydrogen bonding between Glu35
(template-1) and Gln493 (RBD), enabled by the helix curvature, is broken. In contrast, template2 has more direct contacts with RBD than the shorter template-1 variants, so it binds to it more
strongly, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −36 kcal mol−1. However, only two template-2 mutants (H34A and K31W)
have higher affinities to RBD than the original template-2, having 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −45 kcal mol−1.
These simulations also revealed that peptides with a stronger binding covered larger RBD sections
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and reduced the RBD exposure to other potential binding partners. These results show that the
experimental results obtained formulated ACE2194 can provide a good guidance in the mutation of
template-1, but the same mutations are less effective in the larger template-2.
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Figure 22. Modeling of peptide-RBD complexes. a) Complexes of S protein RBD (blue) and two
peptide templates (red). Locations of five S protein mutations examined in the present work are
marked by blue spheres. Amino acid residues changed in singly mutated peptides are marked by
yellow spheres. b) Free energies of binding, ΔGMMGB-SA, between the originally reported S
protein RBD and the wild type or singly mutated ACE2-based peptides. Locations of mutated
peptide amino acids are highlighted in panel a. c) Snapshots of initial and optimized template-1
peptides binding to the original RBD. The sequence of the optimized peptide was obtained after
100 mutation attempts, with 10 ns long MD simulation after each mutation. The final peptide with
the optimized sequence was further relaxed in a 175 ns MD simulation. The initial peptide is shown
as a red helix, with amino acids that are subsequently mutated shown in thin faded yellow licorice.
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The optimized peptide is shown as an orange helix, with mutated amino acids shown in thick
yellow licorice. d) Adaptive evolution of template-1. The plot shows the binding free energies,
ΔGMMGB-SA, between the peptide and the original RBD, presented as a function of the
performed mutation, where the peptide:RBD complexes are relaxed for 10 ns after each mutation
attempt. e) The time evolution of ΔGMMGB-SA between the final optimized peptide and the
original RBD. The average value, obtained from the last 75 ns of the trajectory (gray), is
ΔGMMGB-SA = −57 kcal mol−1. The faded green line shows the data points calculated every 0.1
ns, and the dark green line shows the running average. f) Initial and optimized sequences of
template-1 peptides. The final peptides were optimized for binding to the original and mutant
RBDs, with peptide-RBD complexes relaxed in 10 ns MD simulations after each attempted
mutation.
8.3.3 Adaptive Evolution of Peptide Inhibitors
The above results have clearly demonstrated that suitable peptide templates with
appropriate mutations can acquire a strong binding to specific targets. To optimize such peptides
against specific viral strains, we have developed combined mutation/selection (evolution)
computational algorithms which can guide a multi-step adaptive evolution of the peptides: 1)
Random mutations are introduced into random positions of the peptide templates. 2) Short MD
simulation trajectory of the mutated-peptide:RBD complex are run and followed by a selection or
rejection of the mutation via Monte Carlo (MC) sampling using a Metropolis criterion applied to
the change of the free energy of peptide-RBD binding, 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 . 3) The mutation/selection
process is iteratively repeated until the binding affinity of peptides to the target S protein RBD is
satisfactory. 4) Additional evolution of the molecules might be considered after the MC decisions
to allow for a better internal relaxation of the molecules. Due to a partly stochastic nature of MD
simulations, the randomness in mutations, and the MC selection, different peptides can be obtained
in separate trajectories that correspond to separate local minima of the free energy surface. These
78

peptides form a pool (ensemble) of potential therapeutics evolved for a selected viral strain, which
can be further enriched by considering multiple viral strains.
In Figures 22c–e, coupling of template-1 to RBD was optimized in the adaptive evolution,
where 10 ns MD simulation trajectories were generated after each trial mutation of template-1. Of
the 100 mutations attempted, 13 mutations were accepted, and 11 amino acids were changed
(individual residues can be mutated more than once). Figure 22d reveals the progression of binding
free energies with the mutations of template-1, starting from 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 = −19 kcal mol−1. As
detailed in Figure 22c, during the adaptive evolution, the mutating helical peptide lost its bending
(this change is independent of mutations) and multiple initial contacts with RBD. At the same
time, it shifted with respect to its initial position and formed many new contacts. Peptide residue
E37 formed a salt bridge with the original RBD, while residues Q24, Y26 (mutated), Q30
(mutated), S41 (mutated), and R42 (mutated) formed hydrogen bonds of varying stability with the
original RBD. The resulting peptide bound to RBD with 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 = −70 kcal mol−1 at the end
of thirteen 10 ns long trajectories (associated with individual accepted mutations).
As shown in Figure 22e, additional 175 ns relaxation of this peptide resulted in a slightly
less favorable 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −57 kcal mol−1. Therefore, adaptive evolution requires sufficiently
long relaxation times for a good stabilization of the whole system. Short relaxation times may
result in incomplete peptide adjustments and free energies that can be misleadingly favorable.
Moreover, a faster MC convergence could be achieved by considering the whole free energy
changes rather than the peptide-RBD binding free energies. However, internal reorganizations of
molecules inevitably take part in long trajectories, so the difference in binding energies alone might
be sufficient for the MC decision, as long as additional relaxation is allowed between individual
MC steps.
Next, we adaptively evolved template-1 coupled to three separate singly-mutated RBDs,
chosen from Figure 21d. For simplicity, 100 mutations were attempted, followed by 10 ns
simulations after each attempt. The adaptive evolution gave peptides with 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −(45 to
70) kcal mol−1, as summarized in Figure 23a–c and Figure 22f. Peptides targeting A475V and
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G476S RBDs each had five accepted mutations, respectively, while peptides targeting S477I RBD
had 19 accepted mutations. In the A475V RBD case, one of the early accepted mutations lead to
breaking of the helix secondary structure, and thus to a different peptide-RBD binding mode. This
shows that individual alpha helices without additional stabilization, such as by side branching,
might be too simplistic therapeutics.

80

Figure 23. a–c) Adaptive evolution of template-1 coupled with singly mutated RBDs. d)
Adaptive evolution of template-2 coupled with the original RBD. After attempted mutations,
peptide:RBD complexes were relaxed in 10 ns simulation steps.
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In Figure 23d, the adaptive evolution was performed with a more stable template-2 (𝛼1𝛼2),
but random mutations were only introduced into the 𝛼1 helix, which was in direct contact with the
original RBD. After 12 accepted mutations and 10 changed amino acids, the binding strength
increased from 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 = −36 kcal mol−1 to −60 kcal mol−1. Therefore, the adaptively evolved
template-2 can compete with the whole ACE2, having 𝛥𝐺𝑀𝑀𝐺𝐵−𝑆𝐴 ≈ −50 kcal mol−1 (Figure 1c).
Both the initial and optimized template-2 preserve the curvature of the 𝛼1 helix, despite the
mutation of E35 (to Y35), which is observed to interact with Q493 (RBD). This feature preserves
the binding pattern observed in ACE2:S protein RBD complex.170 However, the salt bridge
between D30 (initial peptide) and K417 (RBD) is lost in the peptide optimized with 10 ns
simulations after mutations.
The work described was performed together with Yanxiao Han, where we shared the work
associated with running and analyzing the computational work, in order to accelerate the
completion of the project and its publication during the COVID-19 pandemic.
7.3 CONCLUSION
In this work, we have demonstrated that ACE2-based peptide templates can be adaptively
evolved by computation using mutation/selection processes to form optimized inhibitors for a
strong and competitive S protein RBD binding. The developed approach can be used to design
peptide inhibitors based on templates extracted from different ACE2 polymorphs, including those
from other species, and other proteins binding to viral pathogens. The optimized inhibitors
obtained in different evolution runs can be collected to form libraries of suitable therapeutics for
different RBD variants. Cocktails (ensembles) of peptide therapeutics could be delivered by
different means to provide a broad-spectrum protection against different SARS-CoV-2 strains.
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